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Abstract 
Objectives: The objectives of this study were to a) examine the distribution of 
chondrocalcinosis (CC), b) determine the risk factors of CC, and c) examine 
the radiographic phenotype of osteoarthritis (OA) associated with CC. 
Methods: Data from the Genetics of Osteoarthritis and Lifestyle (GOAL) 
study were used to describe the radiographic distribution of CC, and to 
conduct a case-control study in which cases with CC were compared with 
controls without CC. All participants had already completed a detailed 
questionnaire, been examined by a research metrologist, had radiographs of 
knees, hands, and pelvis, and had given urine and blood samples. All 
radiographs had been scored for structural radiographic changes of OA, and 
for the presence of CC. Frontal plane knee alignment was measured on all 
knee radiographs. The prevalence (95% confidence interval (CI)) of CC was 
calculated. The odds ratio (OR) and 95% CI were calculated for risk factors 
of CC, and for structural changes associated with CC in joints with OA. This 
was adjusted for age, gender, body mass index (BMI), and OA as 
appropriate, using logistic regression.   
Results: 3170 participants were included in this study. There were 431 cases 
with CC. The overall prevalence (95%CI) of CC in the GOAL population was 
13.7% (12.5% - 14.9%). In the GOAL population, knee was the commonest 
site of CC. However, 42% of participants with CC did not have any knee 
involvement. There was evidence for a generalized predisposition to CC. For 
example, CC at one joint associated with CC at distant joints. Joints with CC 
clustered together more than would be expected by chance alone. At knees, 
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wrists and hips, bilateral CC was more likely to associate with CC at distant 
joints than unilateral CC ± also supporting the existence of a systemic 
predisposition to CC.  
After adjusting for confounding factors, there was an association 
between CC and increasing age, lower current BMI, and OA. The association 
between OA at one joint and CC at the same joint was present for all joints 
except for the hip. There was no association between CC and gender, 
diuretic intake, and selected single nucleotide polymorphisms in enzymes 
involved in pyrophosphate (PPi) metabolism. CC associated with peri-
articular calcification, vascular calcification, low cortical bone mineral density 
(BMD) but not with low cancellous BMD. Self-reported arthroscopy, 
meniscectomy, knee injury, occupational knee joint loading and knee mal-
alignment in the 3rd decade of life associated with knee CC. However, after 
adjusting for confounding factors including OA, there was no association 
between either self-reported or radiographically assessed current knee mal-
alignment and knee CC.  
In joints with OA, the additional presence of CC at the same joint 
associated with a different radiographic phenotype of structural arthropathy. 
For example, in knees with OA, knee CC associated with attrition. In hips 
with OA, hip CC associated negatively with osteophytes, joint space 
narrowing, and sclerosis at the right hip but not at the left. Similarly, in wrists 
with OA, wrist CC associated with sclerosis in the right but not in the left 
wrist; in scapho-trapezioid joints (STJs) with OA wrist CC associated with 
sclerosis on both sides; in metacarpophalangeal joints with OA, wrist CC 
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associated with cysts in the right but not in the left hand; and in 1st 
carpometacarpal joint with OA, wrist CC associated with cysts in the left but 
not in the right hand. In knees with OA, the additional presence of CC at 
distant joints associated with knee attrition. Those with knee CC + OA were 
excluded from this analysis to remove any local effects of CC. CC at distant 
joints did not associate with a distinct structural OA phenotype in other joints 
examined.   
Conclusion: These findings suggest that CC results form a systemic 
predisposition, and that it commonly occurs at other joints in the absence of 
knee involvement. Established risk factors of CC such as age, OA, and 
previous arthroscopy and/or meniscectomy were validated in this study. 
Several novel risk factors of CC e.g. low current BMI, low cortical BMD, and 
vascular calcification were identified. Several novel associations of knee CC 
i.e. early life knee malalignment, self-reported knee injury, and occupational 
knee loading were also recognised. There was convincing evidence to 
suggest that in joints with OA, the additional presence of CC modifies the OA 
phenotype, and that this varies from joint to joint. 
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Chapter 1 Introduction 
1.1 Literature search strategy 
In order to identify the published scientific literature on chondrocalcinosis 
(CC), the bibliographic database (Pubmed) was searched using the following 
NH\ZRUGV VHSDUDWHO\ µFKRQGURFDOFLQRVLV¶ µ&&¶ µFDOFLXP S\URSKRVSKDWH
GHSRVLWLRQ¶ µFDOFLXP S\URSKRVSKDWH GLK\GUDWH GHSRVLWLRQ GLVHDVH¶ µ&33'¶
µ&33'''¶ µSVHXGRJRXW¶ µS\URSKRVSKDWH DUWKULWLV¶ µS\URSKRVSKDWH
metabolisP¶µ$1.+¶RUµ$1.¶Original papers were retrieved where possible 
and the references were reviewed to identify and retrieve other relevant 
publications. Publications in languages other than English were excluded 
except for a few early reports of chondrocalcinosis.  
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1.2 Historical perspective 
Robert Adams, a Dublin surgeon was the first to describe articular cartilage 
calcification in association with chronic joint disease in the year 1854, more 
than 70 years before the description of radiographic articular cartilage 
calcification (Dieppe et al 1989). Radiographic articular cartilage calcification 
known as CC was first described in the late 1920s (Mandl 1927; Werwath 
1928). Werwath drew attention to the association between CC and synovitis 
(Werwath 1928). However, Zitnan and Sitaj were the first to identify CC as a 
cardinal manifestation of a separate disease entity which they termed 
µFKRQGURFDOFLQRVLV DUWLFXODULV¶ Figure 1) (Zitnan et al 1960). Although no 
formal definition exists, CC is regarded as a linear calcification or spotty 
punctuate calcification arranged in a linear fashion occurring in the fibro- or 
hyaline articular cartilage (McCarty et al 1966a).   
 
Figure 1 Knee chondrocalcinosis  
Legend: There is calcification of the meniscus, hyaline articualr cartilage, and 
the capsule. 
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7KHDHWLRORJ\RI µFKRQGURFDOFLQRVLVDUWLFXODULV¶ZDVXQNQRZQWLOl 1962 
when calcium pyrophosphate (CPP) dihydrate crystals were demonstrated in 
WKH V\QRYLDO IOXLG RI ILYH SDWLHQWV ZLWK DSSDUHQWO\ DFXWH µJRXW\¶ DUWKULWLV
(McCarty et al 1962). The similarity of clinical presentation of these patients 
to acute gout led to WKH XVH RI WKH WHUP µSVHXGRJRXW¶ WR GHVFULEH WKH
condition. Two of these five patients also had CC visible on plain radiographs 
(McCarty et al 1962). Therefore, McCarty et al. proposed that CPP crystals 
FDXVH µSVHXGRJRXW¶DUWLFXODU&&DQGDVVRFLDWHGDUWKropathy. At about the 
same time, Zitnan and Sitaj described 27 cases with arthropathy and CC 
(Zitnan et al 1960; Zitnan et al 1963). Twenty-one of the 27 cases belonged 
to 5 families (Zitnan et al 1963). This was the first description of familial CC.  
However, it was soon realised that radiographic CC can be associated 
with the presence of non-CPP crystal species especially hydroxyapatite 
crystals (McCarty, D. J., Jr 1966a, Halverson et al 1986). In a post-mortem 
study, meniscal knee calcification was present in 7.0% cadavers (McCarty et 
al 1966a). The crystal types isolated in menisci with calcification were: CPP 
crystals (3.3%), dicalcium phosphate dihydrate (brushite) crystals (2.3%), 
and hydroxyapatite crystals (1.4%) (McCarty et al 1966a). However, in this 
study hydroxyapatite crystals were reported to associate with solitary 
irregular calcification while CPP and brushite crystals associated with a 
spotty or linear meniscal calcification which is in keeping with CC (McCarty et 
al 1966a). In another synovial fluid study of knee osteoarthritis (OA) patients, 
radiographic knee CC was present in knees with CPP and BCP crystals and 
in knees with CPP crystals alone but not in knee joints with BCP crystals 
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alone (Halverson et al 1986). Thus, while other crystal species may be 
present in joints with radiographic CC, both these studies suggest the 
primary role of CPP crystal deposition in the occurrence of radiographic CC 
(McCarty, D. J., Jr 1966a, Halverson et al 1986).    
Initial reports described patients with florid symptoms, widespread CC 
and impressive joint damage (Zitnan et al 1960; McCarty et al 1962; Zitnan 
et al 1963). However, it soon became apparent that CC may be 
asymptomatic (Phillips et al 1965). After the initial description of pseudogout, 
CPP deposition (CPPD) was reported to associate with several distinct 
clinical manifestations. This led to an expanded classification system for 
CPPD containing a wide range of pseudo-syndromes. However, whether 
these constitute distinct clinical subset is questionable. This complex system 
encouraged inconsistent use of terminology. Terms prefixed by pseudo- do 
not specify the causative crystal, are a source of confusion, and imply that 
CPPD is only of secondary interest compared to gout. Recently, a European 
League Against Rheumatism (EULAR) Task Force suggested simpler 
terminology and classification (Zhang W et al 2011). 
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1.3 Epidemiology  
1.3.1 Incidence of chondrocalcinosis 
There are no studies of incidence of CC in the general population. Two  
retrospective (Reuge et al 2001; Nalbant et al 2003), and two prospective 
(Hernborg et al 1977; Massardo et al 1989) hospital based studies of 
patients with knee OA without knee CC at baseline have examined the 
incidence of de-novo CPPD at the knee (Table 1).  After a follow up of 8 -12 
years, de-novo CPPD occurred in 6.5% - 26.2% of cases without 
radiographic knee CC at baseline. The estimated incidence of radiographic 
knee CC was 0.8% - 2.1% per year, while that of CPPD at the knee was 
2.7% - 5.5% per year. The incidence of CPPD depended on the technique 
used for its identification (Table 1). A higher incidence of CPPD was 
observed in studies using synovial fluid examination in addition to 
radiographic examination than in those employing radiographic examination 
alone. This is because CPP crystals may be present in the absence of 
radiographically visible CC (Ledingham et al 1993a; Pattrick et al 1993).  
Table 1 Incidence of calcium pyrophosphate deposition 
 Number 
of  
patients 
Mean 
follow-up 
(years) 
Prevalence of CPPD 
at end of follow up 
Estimated incidence1  
of CPPD 
 Radiographs  
(CC only) 
Radiographs 
or SF2 analy- 
-sis (CC or 
CPP crystal) 
X-ray 
(CC only) 
Radiographs 
or SF2 
analysis  
(CC or CPP 
crystal) 
Nalbant et 
al 2003 
26 3.6 -/- 3 20.0% -/-3 5.5% 
Massardo 
et al 1989 
31 8.0 6.5% -/-4 0.8% -/-4 
Reuge et 
al 2001 
59 9.0 17.0% 25.0% 1.9% 2.7% 
Hernborg 
et al 1977 
84 13.0 26.2% -/-4 2.1% -/-4 
            1Incidence = (follow up prevalence ± baseline prevalence)/mean duration of follow up                     
.       
2 Synovial fluid 3No radiographs 4No synovial fluid analysis carried out  
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1.3.2 Prevalence of chondrocalcinosis 
1.3.2.1 Community based studies 
The prevalence of CC has been estimated in relatively few community based 
studies (Table 2). The estimates for prevalence of CC vary depending on the 
number of joints surveyed, and the age of the population under study (Ellman 
et al 1975; Trentham et al 1975; Bergstrom et al 1986a; Felson et al 1989; 
Sanmarti et al 1993; Neame et al 2003; Salaffi et al 2005; Ramonda et al 
2009). For example, in the 3 large radiographic studies of middle aged and 
older people, the prevalence of CC at the knee was 7.0% - 8.1%, rising to 
10.0% if knees, wrists and hands; and to 10.4% if knees and hips were 
considered together (Felson et al 1989; Neame et al 2003; Ramonda et al 
2009). Other studies restricted to older people reported a higher prevalence 
of CC (Ellman et al 1975; Bergstrom et al 1986a), whilst studies based in 
residential homes reported an even greater prevalence of CC (Ellman et al 
1975). This may be because they are additionally affected by selection bias ± 
people with symptomatic arthropathies are more likely to be in a residential 
home than in the community (Ellman et al 1975).  
Only a few studies have examined the prevalence of CC in non-
Caucasians. The prevalence of knee CC appears to be lower in Chinese 
men and women (Zhang et al 2006). In a population based study comparing 
the prevalence of CC in Beijing, China, and in Framingham, USA, the age-
standardized prevalence ratio (95% confidence interval (CI)) of knee CC in 
Chinese men was only one-third of that observed in white men (0.34 (0.20±
0.54). The difference was significant for bilateral CC (age-standardized 
prevalence ratio 0.20 (0.10±0.38)) but not for unilateral CC (age-
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standardized prevalence ratio 1.21 (0.56±2.32)) (Zhang et al 2006). A similar 
difference was observed in women (age-standardized prevalence ratio 
(95%CI) 0.43 (0.31±0.59)) (Zhang et al 2006). Compared with white 
subjects, Chinese men and women also had a much lower prevalence of 
radiographic CC in the wrist, with an age-standardized prevalence ratios of 
0.06 (0.01±0.18), and 0.18 (0.10±0.30) respectively (Zhang et al 2006).  
As unilateral knee CC may be a result of local joint pathology (e.g. 
meniscectomy, OA, injury), the authors conclude that the difference in 
prevalence of bilateral knee CC suggests the lack of a systemic 
predisposition in the Chinese population. The authors reported a 15 fold 
higher concentration of calcium in the tap water from Beijing (67.6 mg/litre), 
than in Framingham (4.5 mg/litre). They suggest that high calcium levels in 
the tap water from Beijing possibly suppressed parathyroid hormone 
secretion, thereby protecting against CC (Zhang et al 2006).  
The prevalence of CC also appears to be lower in Saudi Arabian 
people compared to that observed in Caucasians even when only those 
older than 60 years in age are considered (Al-Arfaj et al 2002a).  
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Table 2 Prevalence of chondrocalcinosis in community studies 
Study Age in 
years  
(range) 
Joints 
surveyed 
Number with CC/total 
number of participants 
Prevalence of 
CC 
Community dwelling 
    
Salaffi et al 2005 18-91 Symptomatic 
joints 
9/2155 0.42% 
Neame et al 2003 40-86 Knee 119/1727 7.0% 
Felson et al 1989 63-93 Knee 114/1402 8.1% 
Ramonda et al 2009 >65 Knee, pelvis 169/1629 10.4% 
Sanmarti et al 1993 60-88 Wrist, hand, 
knee 
27/261 10.0% 
Bergstrom et al 1986b 70-79 Wrist, hand, 
knee 
37/352 11.5% 
Bergstrom et al 1986a 79 Wrist, hand, 
knee 
13/81 16.0% 
 
    
Residential home 
    
Trentham et al 19751 41-97 Wrist 2/100 2.0% 
Ellman et al 19751 70-94 Wrist, pelvis, 
knee 
16/58 27.6% 
 
    
Non-Caucasians* 
    
Zhang et al 2006 >60 Wrist 18/2510 0.7% 
Zhang et al 2006 >60 Knee -/- 1.79%2, 
2.67%3 
Al-Arfaj et al 2002a 50-93 Wrist, hand, 
knee 
6/153 3.9%4 
1
 Participants living in residential home only 2 Male 3 Female 4 6.7% in >60 years; 
*community dwelling 
1.3.2.2 Hospital based studies 
The prevalence of CC in hospital based studies varies from 7.0% - 
34.0%. Just as in community based studies, this  depends on the joints 
surveyed, and the age of the population under study (Bocher et al 1965; 
Ellman et al 1981a; Wilkins et al 1983; Gordon et al 1984) (Table 3). Hospital 
based studies have an inherent recruitment bias as they include patients who 
underwent musculoskeletal radiographs for clinical reasons (Bocher et al 
1965; Ellman et al 1981a) or include hospitalized in-patients who are likely to 
have multiple co-morbidities and risk factors for arthritis (Wilkins et al 1983; 
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Gordon et al 1984). Just as has been observed in community based studies, 
hospital based studies from the Middle East also reported a lower prevalence 
RI&&(Malaviya et al 1998; Malaviya et al 2001). 
Table 3 Prevalence of chondrocalcinosis in hospital based studies 
Study Age in 
years 
(range) 
Joints surveyed Number with CC/ 
total number of 
participants 
Prevalence of 
CC 
Bocher et al 
1965 
59-93 Knee 32/455 7.0% 
Ellman et al 
1981a 
>50 Knee 55/574 9.6% 
Gordon et al 
1984 
>55 Hand, wrist, knee, 
pelvis 
20/127 15.7% 
Wilkins et al 
1983 
65-97 Hand, wrist, knee, 
pelvis 
34/100 34.0% 
 1.3.2.3 Autopsy studies.  
Between 10.0% and 22.0% of post-mortem knee radiographs have evidence 
of CC (McCarty et al 1966a; Gordon et al 1984b; Mitrovic et al 1988; Sokoloff 
et al 1988). In three studies, CPP crystals were found in all CC cases where 
its presence was specifically sought (McCarty et al 1966a; Mitrovic et al 
1988; Sokoloff et al 1988) while in another study no CPP crystals were 
identified in those with radiographic CC and severe knee OA (Gordon et al 
1984b).                           
As would be expected, the prevalence of CPP crystals in post-mortem 
knee aspirates varies according to the joint aspirated, and the presence or 
absence of joint effusion. For example, the prevalence of CPP crystals in 
post-mortem joint aspirates was 30% in knees with a detectable joint effusion 
(Gordon et al 1984b), 8% (11 of 138) in knees irrespective of the presence of 
a detectable joint effusion (Moens et al 1985), and only 0.3% (2 of 70) at the 
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1st metatarsophalangeal joints (MTPJs) (Wall et al 1983). Similarly, on post-
mortem examination, the estimated prevalence of CPP crystals in ankle of 
those older than 18 years was 1.6% (Muehleman et al 2008). 
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1.4. Risk factors 
1.4.1 Age  
Early descriptions of CC suggested that it predominantly affects young or 
middle aged individuals with a median age of onset of symptoms in the 4th 
decade of life (Zitnan et al 1963). Subsequent hospital based case series 
suggested that CC predominantly affects older people (Moskowitz 1966; 
Skinner et al 1969; Moskowitz et al 1973; Bjelle et al 1974; Fam et al 1981; 
Gordon et al 1984; Canhao et al 2001). Since then, the relation between age 
and CC has been examined in several hospital (Ellman et al 1981a; Wilkins 
et al 1983), community (Bergstrom et al 1986b; Felson et al 1989; Sanmarti 
et al 1993; Neame et al 2003; Zhang et al 2006), and autopsy studies 
(Mitrovic et al 1988; Sokoloff et al 1988; Muehleman et al 2008).  
 The prevalence of knee CC increases with age (Figure 2). In a 
community based study in Nottinghamshire, UK, the prevalence of knee CC 
increased from 3.7% at age 55 - 59 years to 17.5% at age 80 - 84 years 
(Neame et al 2003). Similarly, in the Framingham study, there was more than 
a doubling in the prevalence of knee CC with each 10 years increase in age 
after the age of 60 years [Relative Risk (95%Confidence Interval) (RR 
(95%CI) of CC per 10 year increase in age 2.40 (1.97-2.91)] (Felson et al 
1989). Similar findings have been reported in previous Swedish studies 
(Bergstrom et al 1986a; Bergstrom et al 1986b). In these studies, the 
prevalence of knee CC at age 70, 75, and 79 years was 6.8%, 8.0% and 
12.3%, while that of CC at either knee, wrist or hand was 7.5%, 10.1% and 
16.0% respectively (Bergstrom et al 1986a; Bergstrom et al 1986b).  
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Hospital based studies report a similar dramatic increase in 
prevalence of CC with increasing age. In one hospital based study, the 
prevalence of CC at any site (either knee, wrist, hands or pelvis) rose from 
15% in the 65 - 74 year age group, to 36.4% in the 75 - 84 year age group, 
and to 44% in the 85 - 94 year age group (Wilkins et al 1983). There is also 
an age associated increase in prevalence of CPP crystal deposition at 
unusual sites like the ankle (Muehleman et al 2008). In a post-mortem study, 
the prevalence of CPPD at the ankle rose from 0.07% in the 50 - 59 years 
age group, to 1.01% in the 60 - 69 years age group, to 2.4% in the 70 - 79 
years age group, and to 3.5% in those older than 80 years in age 
(Muehleman et al 2008). In a post-mortem study using Faxitron x-ray device, 
cartilage calcification increased with increasing age irrespective of the grade 
of OA, suggesting that ageing may have a greater contribution to cartilage 
calcification than OA (Mitsuyama et al 2007), however, other studies suggest 
that the association between CC and OA is independent of age (See section 
1.3.4).  
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Figure 2 Prevalence of knee chondrocalcinosis increases with age 
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1.4.2 Gender 
Many hospital based case-series suggest that CC is more common in 
women than in men, reporting that between 62.0% - 72.4% of patients with 
CC were women (Moskowitz 1966; Skinner et al 1969; Moskowitz et al 1973; 
Fam et al 1981; Dieppe et al 1982; Louthrenoo et al 1999; Canhao et al 
2001). However, a Swedish hospital based case-series found equal numbers 
of men and women in 50 consecutive CC cases with arthropathy (Bjelle et al 
1974). The notion that CC is more common in women than in men is 
supported by several other hospital (Bocher et al 1965; Wilkins et al 1983; 
Gordon et al 1984), community (Bergstrom et al 1986a; Sanmarti et al 1993; 
Zhang et al 2006), and autopsy studies (Mitrovic et al 1988) (Table 4). 
However, other hospital (Bocher et al 1965; Ellman et al 1981a), community 
(Felson et al 1989; Al-Arfaj et al 2002a; Neame et al 2003), and autopsy 
(Sokoloff et al 1988) studies do not find any difference in prevalence of CC 
according to their gender (Table 4).  However, when the demographics of 
gender and age distribution in the community are taken into account, both 
the Nottinghamshire study and the Framingham study suggest an 
approximately equal gender distribution (Felson et al 1989; Neame et al 
2003). Similarly, the age independent association between gender and CC in 
the ProVA study (Ramonda et al 2009) became non-significant after 
adjusting for OA (Musacchio et al 2011). Therefore, the association between 
gender and CC observed in earlier studies may be due to the fact that knee 
OA is more common in women, and when present is more likely to be severe 
than in men (van Saase et al 1989).  
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Table 4 Prevalence of chondrocalcinosis according to gender 
Study Joints surveyed Prevalence of CC Difference  in 
prevalence 
  Women Men women ±  men 
(95%CI)* 
Community dwelling 
    
Neame et al 2003 Knee 6.1% 8.2% -2.1% (-4.7,0.5)1 
Felson et al 1989 Knee  9.0% 8.1% 0.9% (-2.1,3.9)1 
Ramonda et al 2009 Knee, Pelvis 12.8% 7.0% 5.8% (2.9,8.7)1 
Sanmarti et al 1993 Wrist, hand, knee  14.1% 5.8% 8.3% (1.2,15.4) 
Bergstrom et al 1986b Wrist, hand, knee 14.7% 5.6% 9.1% (2.9,15.3) 
Ellman et al 19752 Wrist, pelvis, knee 32% 0% 32.0% (44.9, 19.1) 
 
    
Hospital based 
    
Ellman et al 1981a3 Knee 8.3% 12.4% -4.1% (-9.6, 1.4) 
Bocher et al 19654 Knee 6.7% 7.9% -1.2% (-6.8, 4.4) 
Gordon et al 1984 5 Hand, wrist, knee, 
pelvis 
24.3% 3.7% 20.6% (9.6,31.6) 
Wilkins et al 1983 4 Hand, wrist, knee, 
pelvis 
40.6% 19.4% 21.2% (3.1,39.3) 
Mitrovic et al 1988 6 Knee 26.1% 15.4% 10.7% (-3.1,24.5) 
 
    
Non-Caucasian 
    
Zhang et al 2006 Knee 2.67% 1.79% 0.88% (-0.30, 2.0) 
Zhang et al 2006 Wrist 1.0% 0.3% 0.70% (0.09,1.3) 
Al-Arfaj et al 2002a Wrist, hand, knee 6.7% 7.3% -0.60% (-11.8,10.7) 
1Non-significant after adjusting for age - Neame et al. 2003, and Felson et al. 1989; and 
knee OA (Musacchio et al 2011).  2Residential home 3Radiology files 4Elderly care hospital 
5Medical inpatients 6Autopsy. Trentham (Trentham et al 1975) only recruited men. Salaffi 
(Salaffi et al 2005) and Sokoloff (Sokoloff et al 1988) do not give detailed information about 
gender. Patients in (Bergstrom et al 1986a) were included in (Bergstrom et al 1986b). 
*The difference in prevalence and 95% confidence interval (CI) were calculated as:  
p1 - p2 +/-  [ ¥ (p1-(1-p1) + (p2-(1-p2).  px, nx, is prevalence of CC and number of 
participants.                   n1                   n2   
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1.4.3 Heredity 
The occurrence of familial CC has been reported since early description of 
CC (Zitnan et al 1963; McCarty 1976). In fact, 21 of the 27 CC cases 
described by Zitnan and Sitaj belonged to 5 families (Zitnan et al 1963). Also, 
of the 12 cases initially described by McCarty et al., 3 had other family 
members affected by CC (McCarty 1976). In another study, 57 of the 160 CC 
cases in Chiloe islanders were from 12 families (Reginato 1976). A high 
degree of consanguinity in families with CC reported in this study further 
supported the hypothesis that CC may be hereditary (Reginato 1976). This 
hypothesis was further supported by the fact that autosomal dominant 
familial CC with varying degrees of associated arthropathy was reported from 
different parts of Europe, the Americas and North Africa at about the same 
time (Perry et al 1969; Reginato et al 1970; Reginato et al 1974; Reginato et 
al 1975; Rodriguez-Valverde et al 1980; Bjelle 1981; Gaudreau 1981; 
Milazzo et al 1981; Nunez-Roldan et al 1981; Bjelle et al 1982a; Bjelle et al 
1982b; Richardson et al 1983; Hamza et al 1990; Doherty et al 1991). Taken 
together, these reports suggested a strong hereditary component to the 
µDSSDUHQWO\VSRUDGLF&&¶7ZRPDLQFOLQLFDOSDWWHUQVRIKHUHGLWDU\&&ZHUH
described (Reginato 1976):  
a) IORULG HDUO\ SRO\DUWLFXODU && ZLWK IUHTXHQW µSVHXGRJRXW¶ VSLQDO
involvement, and severe symptoms; and  
b) mild oligoarticular CC with a late age of onset of symptoms.   
Subsequent hospital based studies showed that 11.0%-27.0% of 
cases with apparently sporadic CC had at least one other affected family 
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member, suggesting that up to a quarter of sporadic CC cases were in-fact 
familial (Rodriguez-Valverde et al 1980; Fernandez Dapica et al 1986; Balsa 
et al 1990). However, these studies have many significant limitations. They 
lack a control group, have hospital based recruitment, and have a high rate 
of non-participation among family members. Being hospital based, these 
studies are likely to have cases with severe polyarticular CC or those with 
OA and CC. The familial association could be mediated by OA, which runs in 
families (Sandell 2012), and is an established risk factor for CC (See chapter 
1.4.4 Osteoarthritis).  
Other larger studies suggest that apparently sporadic CC is not 
hereditary in nature. In a controlled study, the prevalence of CC was 
compared between 122 siblings of index cases with knee OA and CC 
awaiting joint replacement surgery, and 1727 community dwelling adults 
(Zhang et al 2004). The prevalence of CC was twice as high in siblings of 
index cases compared to the community controls (13% vs. 6.9%). However, 
after controlling for age, gender, body mass index (BMI), and knee OA the 
prevalence of CC was no greater in siblings of index cases with OA and CC, 
than in community dwelling adults (Zhang et al 2004). The adjusted Odds 
Ratios (aOR) (95%CI) were 1.16 (0.58 to 2.29) for CC irrespective of OA 
status, 1.07 (0.41 to 2.78) for isolated CC (i.e CC without OA), and 1.09 
(0.44 to 2.68) for CC with OA (Zhang et al 2004). 
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1.4.4 Osteoarthritis  
The early descriptions of CC were in patients with significant structural 
arthropathy (Zitnan et al 1963; Dieppe et al 1989). In early hospital based 
studies, 50.0% ± 90.4% of joints with CC had structural changes of OA 
(Bocher et al 1965; Bjelle et al 1974; McCarty 1974a). OA and CC were 
reported to co-localise at knees, wrists, MCPJs, hips, shoulders, elbows, and 
ankles. Subsequent large community based studies showed a smaller but 
strong association between OA and CC (Felson et al 1989; Sanmarti et al 
1996; Neame et al 2003; Ramonda et al 2009). The association between OA 
and CC was not due to confounding by age or gender as the association 
persisted after adjusting for these factors (Felson et al 1989; Sanmarti et al 
1996; Neame et al 2003; Ramonda et al 2009) (Table 5).  
Most large studies were focussed on knee CC and OA. In the only 
large study to examine the association between radiographic hip OA and CC 
(at either knee, hip or symphysis pubis), there was no association between 
CC and radiographic hip OA, suggesting that the association between OA 
and CC may be joint specific, and may predominantly exist at the knee 
(Ramonda et al 2009). In a later publication from the same dataset, both 
clinically diagnosed knee OA (p=0.05), and knee OA according to the 
American College of Rheumatology classification criteria (p=0.003) 
associated with CC at knee, hip, or symphysis pubis after adjusting for age, 
and gender (Musacchio et al 2011). However, there was no association 
between clinically diagnosed hip OA, and hip OA according to the American 
College of Rheumatology classification criteria and CC at knee, hip or 
symphysis pubis (Musacchio et al 2011). The association between OA and 
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CC has not been shown in some studies from the Middle East, possibly due 
WRD YHU\ ORZ SUHYDOHnce of CC in these populations (Malaviya et al 
1998; Malaviya 2001).  
Although, the association between knee CC and prevalent knee OA is 
well established, findings from the Framingham study suggest that knee CC 
does not result in incident knee OA (aRR (95%CI))1.20 (0.50-2.70)) (Felson 
et al 1997). 
Table 5 Association between chondrocalcinosis and osteoarthritis 
Study  Joints examined  age adjusted OR 
(95% CI) 
Community 
dwelling 
  
Neame et al 2003 Knees  2.45 (1.65-3.65)1 
Felson et al 1989 Knees 1.52 (1.22-1.90)1,2 
Sanmarti et al 1996 Knee OA and CC at knees, hips or wrist  4.30 (1.60-11.8)   
Musacchio et al 
2011   
Knee OA and CC at knees, symphysis 
pubis or hips  
3.02 (1.95-4.69)3 
Musacchio et al 
2011 
Hip OA and CC at hips, symphysis 
pubis or knees 
1.06 (0.64-1.76)3  
 
Hospital based 
  
Gordon et al 1984 Knees 4.20 (1.40-12.8) right knee   
3.00 (1.10-8.2) left knee 
1 Additionally adjusted for gender 2 Relative Risk (95%CI) 3Crude. 
Radiographic studies underestimate the prevalence of CPPD in those 
with OA (Gibilisco et al 1985; Viriyavejkul et al 2007). For example, at the 
time of total joint replacement for knee OA, 17% patients without 
radiographic knee CC had CPP crystals (Viriyavejkul et al 2007). Other 
studies suggest that from one quarter to one half of OA knees with CPP 
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crystals do not have radiographic CC (Ledingham et al 1993a; Pattrick et al 
1993).  
The prevalence of CPP crystals is even higher in knees with OA and 
joint effusion in the absence of any radiographic CC. For example, in those 
with symptomatic knee OA with joint effusion, and without radiographic knee 
CC, CPP crystals were present alone in 13 of 72 (18.1%) cases, and co-
existed with hydroxyapatite in 29 of 72 (40.2%) cases (Gibilisco et al 1985).   
CPP crystals, basic calcium phosphate (BCP) - principally 
hydroxyapatite - crystals, and OA co-associate with each other. The 
association could be mediated by pronucleating changes in cartilage matrix 
e.g. reduced type 2 collagen, excess type 1 collagen (with small amounts of 
type 2 collagen), few large proteoglycans; alterations in Pi/PPi levels, 
apoptotic chondrocytes which serve as a nidus for crystal formation, and 
hypertrophic chondrocytes ± a pro-mineralizing chondrocyte phenotype 
(Jubeck et al 2008; Ryan et al 1995; Masuda et al 1991; Rosenthal et al 
1999). Two studies suggest that BCP and CPP crystals coexist more often 
than being found alone (Gibilisco et al 1985; Halverson et al 1986).  In 
hospital based case series, either CPP or BCP crystals were present in 
28.0% ± 59.0% of knees with symptomatic OA (Gibilisco et al 1985; 
Ledingham et al 1993a; Pattrick et al 1993; Derfus et al 2002; Nalbant et al 
2003; Viriyavejkul et al 2007). In symptomatic knee OA, CPP crystals were 
present alone in 7.0% - 42.0% cases, and in combination with apatite or 
alizarin red positivity in 16.0% - 40.0% of cases (Gibilisco et al 1985; 
Halverson et al 1986; Ledingham et al 1993a; Pattrick et al 1993; Derfus et al 
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2002; Nalbant et al 2003; Viriyavejkul et al 2007). In two recent studies, BCP 
crystals were present in all joints with end stage OA while CPP crystals were 
identified in only 10.0% hips, and 18.0% knees respectively (Fuerst et al 
2009a; Fuerst et al 2009b). This suggests that the deposition of BCP crystals 
is integral to the process of end stage OA. However, in joints with cartilage 
defects and cortical damage, intra-articular hydroxyapatite crystals may also 
originate from the subchondral bone (Dieppe et al 1984).   
1.3.4.1 Association between severity of osteoarthritis and chondrocalcinosis  
The prevalence of CPPD increases with severity of OA at the index joint. For 
example, in clinic based studies of knee OA, the prevalence of CPPD at the 
knee varies between 8.0% ± 33.0% (Massardo et al 1989; Dougados et al 
1992; Ledingham et al 1993a; Reuge et al 2001; Neogi et al 2006), 
increasing to 31.8% - 52.9% at the time of joint replacement surgery (Derfus 
et al 2002; Viriyavejkul et al 2007). While at the hip, the prevalence of CC 
was 1.5% in clinic based studies (Ledingham et al 1992), increasing only to 
6% at the time of joint replacement surgery (Sokoloff et al 1988) (Table 6).  
  
42 
 
Table 6 Prevalence of chondrocalcinosis and osteoarthritis severity 
 Age in 
years 
(range) 
Joints surveyed Number with 
CC/ Total 
number of 
participants 
Prevalence 
of CC 
Knee OA: clinic based 
radiographic studies  
    
Massardo et al 1989; 
Dougados et al 1992 
50-79 Hand 2/31 6.6% 
Neogi et al 2006 47-93 Knee 23/265 8.8% 
Massardo et al 1989 50-79 Knee 3/31 10.0% 
Dougados et al 1992 -/- Knee 26/259 10.0% 
Neogi et al 2006 70-79 Knee 69 /373 18.5% 
Ledingham et al 1993a 34-91 Knee, pelvis, hand, 
wrist,shoulder,spine 
83/252  
Knee OA: clinic based 
synovial fluid studies 
    
Reuge et al 2001 -/- Knee 41/227 18.1% 
Ledingham et al 1993a 34-91 Knee -/- 28.0% 
Pattrick et al 1993 33-96 Knee 97/300 32.0% 
 
    
Knee OA: total joint 
replacement studies  
    
Derfus et al 2002 52-90  Knee 16/531 30.2% 
Sokoloff et al 1988 
 Knee 18/55 32.7% 
Viriyavejkul et al 2007 69 (mean) Knee 53/1012 52.9% 
 
    
Hip OA: clinic based 
radiographic studies  
    
Ledingham et al 1992 29-86 Hip 2/133 1.5% 
Ledingham et al 1992 29-86 Knee, hand, wrist, 
shoulder, spine 
21/133 15.8% 
Hip OA: total joint 
replacement study 
    
Sokoloff et al 1988 53-82 Hip 5/84 6.0% 
1
 synovial fluid analysis 225 radiographic CC, 10 both CC and CPP on synovial fluid and 18 
CPP crystals only on synovial fluid   
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1.4.5 Other musculoskeletal conditions  
Early studies reported that CC associates with hyperuricemia, gout, and 
rheumatoid arthritis (RA) (Moskowitz et al 1965; McCarty 1966b; Moskowitz 
et al 1967). Subsequent hospital based controlled studies did not confirm any 
association between CC and hyperuricemia (Hollingworth et al 1982), but 
reported an association between CC and gout (Stockman et al 1980), which 
may be mediated by:  
x µHSLWD[\¶ - deposition of one crystal type on another, or  
x generalized predisposition to crystal deposition and growth. 
The latter could be mediated by either an excess of pronucleating factors or 
a paucity of inhibitors of crystal formation and growth. Such phenomena 
occur in vivo. This is supported by the presence of pronucleating factors like  
gamma globulin and collagen fibre in the synovial fluid and serum of gout 
patients (McGill et al 1991a; McGill et al 1991b), and the presence of a 
macromolecular inhibitor of hydroxyapatite crystal growth in the serum 
(Garnett et al 1990). Garnett et al reported that 50% of the inhibitory action of 
serum on hydroxyapatite crystal growth is mediated by albumin (Garnett et al 
1990). Recent studies suggest that albumin, and fetuin A have a dual 
inhibitory and seeding effect on hydroxyapatite crystal formation (Wu et al 
2009). Other examples of physiologic inhibitors of crystal formation and 
growth include lithostathine in pancreatic juice (Bernard et al 1992); 
uropontin, citrate, PPi, osteopontin, glycoproteins, glycosaminoglycans, 
proteoglycans in urine (Shiraga et al 1992; Worcester 1994). On the other 
hand ferric ion, phospholipids, proteolipid phospholipid complex, and calcium 
phospholipid phosphate complex increase crystal nucleation and their 
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excess may predispose to the co-existence of different types of crystals 
(Boskey et al 1982; Raggio et al 1986; Naughton et al 2001).   
The association between CPPD and RA has been examined by 
several groups. Several hospital based case-control studies report a 
negative association between radiographic CC, or synovial fluid CPP crystal, 
and RA (Hollingworth et al 1982; Doherty et al 1984; Brasseur et al 1987). 
Similarly, a large community based study did not find any association 
between RA and CC at either knees, hips, or symphysis pubis (Ramonda et 
al 2009). On the contrary, examination of defleshed skeletal remains 
suggested an association between CC, and both RA and 
spondyloarthropathy (Rothschild 2007). A retrospective hospital based case 
series reported that 25.8% of synovial fluid aspirates from patients with RA 
had CPP crystals (Gerster et al 2006). The high prevalence of CPP crystal in 
the latter study may be due to age (mean age 64.5 years), and long disease 
duration of RA (mean 12 years), which may in turn result in secondary joint 
degeneration (Gerster et al 2006). In summary, current evidence suggests 
that there is either a negative or no association between CC and RA.   
There is no association between 3DJHW¶V GLVHDVH RI ERQH DQG &&
(Boussina et al 1976) )RUUHVWLHU¶V GLVHDVH YHUWLFDO VSLQDO RVVLILFDWLRQ ZLWK
characteristic dripping wax appearance) is distinct from CPPD (Rogers et al 
1985).   
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1.4.6 Injury  
Previous joint injury is a risk factor for CC at the index joint. The joint injury 
may be isolated e.g. surgery or meniscectomy, or recurrent e.g. 
hypermobility syndrome. This association is supported by a case-control 
study and by several case-series.    
x After a mean follow-up of 25 years, there was a five-fold increase 
in the risk of CC in knee joints with previous meniscectomy when 
compared to the opposite knee (Doherty et al 1982). A similar 
result was found by comparing the index knee with previous 
meniscectomy to an age, and gender matched control group 
(Doherty et al 1982). 
x Of the 76 patients with knee CC seen at a hospital, 18 were 
young (mean age 43.1 years) and developed CC in a joint which 
had previously been injured or operated upon (de Lange et al 
1985). Significant structural changes of OA were present in 2 
young patients only, and an underlying predisposition to CC was 
absent in all these patients (de Lange et al 1985). 
x 65.5% of 85 patients with CPPD identified in a review of 3228 
arthroscopies had a past history of knee injury, meniscectomy or 
other knee surgery (Fisseler-Eckhoff et al 1992).    
x Four of the seven cases with long standing hypermobility 
syndrome, and knee synovitis had CPP crystals (Bird et al 1978). 
However, all four also had severe knee OA in the index joint, and 
CPPD may be secondary to OA.  
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x Four cases with localized joint hypermobility, and CPPD in the 
index joint with or without co-existing OA were reported (Settas et 
al 1982).  
1.4.7 Metabolic diseases 
A number of metabolic conditions were initially reported to associate with CC 
(Hamilton 1976). While the association between diabetes and CC may be 
confounded by age, other reported associations between uncommon 
GLVHDVHVOLNH:LOVRQ¶VGLVHDVHDQGRFKURQRVLVZHUHEDVHGRQFDVH reports 
of florid CC in young patients (Jones et al 1992). A case control study did not 
show any association between hypothyroidism and CC (Chaisson et al 
1996). Two subsequent detailed literature reviews suggest that 
haemochromatosis, hyperparathyroidism, hypomagnesemia and 
hypophosphatasia are risk factors for CC and their presence should be 
specifically sought in young (<50 years) patients, especially those with florid 
polyarticular CC (Jones et al 1992; Richette et al 2009).     
1.4.7.1 Haemochromatosis 
Schumacher was the first to report CC in a patient with haemochromatosis 
(Schumacher 1964). Subsequently, in a hospital based case series, 
structural arthropathy with CC was reported at the knees, wrists, hips, pubic 
symphysis, and MCPJs in 12 of 32 cases with haemochromatosis (Hamilton 
et al 1968). Numerous laboratory studies suggest that iron overload directly 
leads to CC by inducing cartilage matrix changes (Sokoloff 1963), 
chondrocyte toxicity (Brighton et al 1970), and free radical formation (Blake 
et al 1985). Other studies also suggest that the arthropathy of 
haemochromatosis is related to iron overload (Ross et al 2003), and that it 
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may be mediated by the middle fragment of parathyroid hormone (44-68 
PTH) (Pawlotsky et al 1999).  
Although the association between haemochromatosis and CC is 
proven beyond doubt, there is little evidence to support an association 
between single nucleotide polymorphisms (SNPs) which result in 
haemochromatosis and CC. For instance, a large community based cross-
sectional study in Rotterdam did not find any association between the 
genotypes associated with greater iron load (C282Y/C282Y or C282Y/H63D) 
and CC. This may be due to a low penetrance of C282Y/C282Y or 
C282Y/H63D genotypes or due to the fact that factors other than iron 
overload are responsible for the development of CC (Alizadeh et al 2007). 
However, the findings of this study are contrary to that of a smaller hospital 
based study from the UK, which reported an association between SNPs 
leading to haemochromatosis and CC (Timms et al 2002).  
1.4.7.2 Hyperparathyroidism 
CC was first described in six patients with hyperparathyroidism seen over a 
ten year period at the Taplow and Hammersmith hospitals (Bayswater 1959). 
Early retrospective studies suggested a high prevalence of CPPD (18.0%- 
40.0%) in Caucasian hyperparathyroid patients (Dodds et al 1968; Glass et 
al 1976; Pritchard et al 1977; McGill et al 1984). Of interest, the prevalence 
of CPPD was lower (6.1%) in Japanese hyperparathyroid patients (Yashiro 
et al 1991).  
The association between CC and hyperparathyroidism is supported by 
several hospital bases studies. In a case-control study, 30.7% of cases with 
48 
 
hyperparathyroidism had CC compared to 3.4% age-gender matched 
controls (Rynes et al 1978). This study suggests that CC is more common in 
hyperparathyroid patients than in age, and gender matched controls. 
Moreover, in other studies hyperparathyroid patients with CC were younger 
than controls with CC without any clinical hyperparathyroidism, suggesting 
that hyperparathyroidism contributed to CPPD (Pritchard et al 1977; Yashiro 
et al 1991). Finally, hyperparathyroid patients with CPPD were reported to 
have higher levels of parathyroid hormone, and a larger parathyroid 
adenoma (McGill et al 1984). However, as would be expected, the 
association between CC and hyperparathyroidism is influenced by age as 
hyperparathyroid patients with CC are reported to be older than 
hyperparathyroid patients without CC (Dodds et al 1968; Glass et al 1976; 
Pritchard et al 1977; Rynes et al 1978; McGill et al 1984; Yashiro et al 1991). 
Evidence for the role of hypercalcemia as a pathogenic mechanism of 
CC in hyperparathyroidism is conflicting. Two hospital based studies suggest 
that hyperparathyroid patients with CC have serum calcium levels that are 
comparable to that observed in hyperparathyroid patients without CC 
(Pritchard et al 1977; Rynes et al 1978), while other studies suggest 
hyperparathyroid patients with CC have higher serum calcium than 
hyperparathyroid patients without CC (McGill et al 1984; Yashiro et al 1991). 
Recent in-vitro studies show that high extracellular calcium levels increase 
the expression of both ANK and ENPP1 mRNA and protein, which result in 
elevated ePPi levels (Cailotto et al 2011). This may explain the association 
between hyperparathyroidism and CC. 
49 
 
The role of parathyroid hormone (PTH) in the aetiopathogenesis of 
CPPD in the absence of clinical or biochemical hyperparathyroidism has 
been examined by four hospital based studies. Three previous case series 
reported similar levels of PTH and calcium in patients with and without CPPD 
(McCarty et al 1974b; Alexander et al 1982; Huaux et al 1986). However, 
recently patients with sporadic CPPD have been reported to have high 
middle fragment PTH (44-88 PTH) in their serum, suggesting a role for 
parathyroid hormone in the pathogenesis of sporadic CPPD in the absence 
of clinically overt hyperparathyroidism (Pawlotsky et al 2008). In-vitro studies 
show that mid-region PTH fragment may be biologically activity, and result in 
osteoblast proliferation, cartilage hypermineralization, and new bone 
formation (Pawlotsky et al 2008).  
1.4.7.3 Hypomagnesemia 
The association between hypomagnesemia and CC is supported by several 
case-series, and small case-control studies. A case of post-
parathyroidectomy pseudogout with acute hypomagnesemia was first 
described in 1966 (Melvin 1966). Subsequently, several cases of CC in 
SDWLHQWV ZLWK µLGLRSDWKLF K\SRPDJQHVHPLD¶ (McCarty et al 1974b), and 
hypomagnesemia due to renal loss (Runeberg et al 1975; Ellman et al 1980) 
were described. Similar reports and the description of GitelPDQ¶VYDULDQWRI
%DUWWHUV¶ V\QGURPH OHG WR WKH HVWDEOLVKPHQW RI K\SRPDJQHVHPLD - 
predominantly due to renal loss - as a cause of CC (Gitelman et al 1966; 
Munoz-Fernandez et al 1994; Smilde et al 1994). The reported association 
between diuretic use and knee CC has also been hypothesized to be 
mediated by diuretic induced hypomagnesemia (Neame et al 2003). 
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 Hypomagnesemia due to gastro-intestinal losses may also lead to 
CPPD. In a cross sectional study of patients on total parenteral nutrition 
chronic hypomagnesemia associated with knee CC (OR (95%CI) 13.5 (2.76-
127.3)) (Richette 2007). Three cases of chronic hypomagnesemia due to 
short bowel syndrome were also previously reported with symptomatic CPPD 
(Richette et al 2005).  
While severe hypomagnesemia associates with CC in rare clinical 
scenarios, it is unclear if there is any role of mild hypomagnesemia in the 
pathogenesis of sporadic CC or CPPD. This is as previous hospital based 
studies show that serum magnesium levels are similar in people with and 
without apparently sporadic CPPD (McCarty et al 1974b; Alexander et al 
1982; Huaux et al 1986; Ramonda et al 2009).   
1.4.7.4 Hypophosphatasia 
The association between hypophosphatasia and CC is based on several 
case reports of florid polyarticular CC at a young age (Birtwell et al 1967; 
O'Duffy 1970; Eade et al 1981; Whyte et al 1982; Macfarlane et al 1986; 
Chuck et al 1989). However, low alkaline phosphatase levels do not seem to 
play a role in the occurrence of apparently sporadic CPPD in the older age 
group. There was no difference in serum alkaline phosphatase levels in 
those with and without CPPD in the absence of clinical features suggestive 
of hypophosphatasia (McCarty et al 1974b; Alexander et al 1982; Huaux et al 
1986). While some studies report low synovial fluid alkaline phosphatase in 
joints with CPP crystals (Russell et al 1970; Yaron et al 1970; Howell et al 
1976; Tenenbaum et al 1981), other studies do not report any differences in 
synovial fluid alkaline phosphatise levels in those with and without CPPD 
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(McCarty et al 1971; Altman et al 1973; Jacobelli et al 1978; Rachow et al 
1985). In summary, although CC associates with hypophosphatasia, these 
studies do not support any role for low alkaline phosphatase levels in the 
aetiopathogenesis of apparently sporadic CC at a population level.  
1.4.8 Summary of risk factors of CC  
As discussed above, there are many reported associations of CC. However, 
there are only a few established risk factors of CC.  
These include: 
1. Increasing age  
2. OA  
3. Metabolic diseases 
a. Hyperparathyroidism 
b. Haemochromatosis  
c. Hypomagnesemia  
d. Hypophosphatasia 
4. Familial 
a. ANKH gene mutations 
b. CCAL 1 gene mutations (secondary to non-dysplastic OA) 
5. Meniscectomy (for knee CC)   
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1.5 Classification of CPPD 
1.5.1 Introduction  
In the early 1960s, patients with CC were classified into distinct sub-groups 
based on their dominant clinical features (McCarty 1966b; McCarty 1976). 
This classification was influenced by early descriptions of patients with florid 
CC and severe arthropathy (Figure 3) (McCarty et al 1963; Zitnan et al 
1963) 7KLV FODVVLILFDWLRQ 0F&DUW\¶V FODVVLILFDWLRQ DOWKRXJK FRPSOH[ DQG
reliant on the severe and rare manifestations of CPPD effectively illustrates 
the heterogeneity of clinical features associated with CPPD (McCarty 1976).  
Figure 3 Severe knee osteoarthritis with chondrocalcinosis 
Legend: Tri-compartmental knee OA associated with knee CC. The CC is 
better visualised in the left knee.  
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1.5Ǥ ?ǯ  
Type A (Pseudogout): acute/sub-acute self limiting mono- or oligo-articular 
attacks of synovitis lasting 1 day to 4 weeks. 
Type B (Pseudo-rheumatoid arthritis): seen in 5% of cases, characterised by 
subacute/chronic polyarticular arthropathy lasting 4 weeks to several months, 
with morning stiffness, fatigue, synovial thickening, localized oedema, and 
limitation of joint movement. 
Types C (Pseudo-osteoarthritis with superimposed acute attacks): seen in 
25% of cases. There is chronic pain, and restriction of movement with 
superimposed attacks of pseudogout. (Figure 3)   
Types D (Pseudo-osteoarthritis without superimposed acute attacks): seen in 
25% of cases. There is chronic pain, and restriction of movement but no 
acute attacks. (Figure 3)  
Type E Lanthanic (Asymptomatic) CPPD: probably the most common type 
(Figure 4) 
Type F Pseudoneurotrophic: rarely seen, but with advanced destruction of 
the joint on X ±ray, and marked symptoms. (Figure 5) 
Other Patterns: stiffening and straightening of the spine with true bony 
ankylosis (pseudo ankylosing spondylitis), and proximal stiffness with 
shoulder restriction (pseudo-polymyalgia rheumatica).   
The apparent complexity of this system, common evolution from one 
form to another, and possible concurrence of different types within the same 
LQGLYLGXDOOHGWRWKHGHYHORSPHQWRIDVLPSOHUµ(XURSHDQ¶FODVVLILFDWLRQ
(Currey 1970; Russell et al 1970; Doherty et al 1986). 
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Figure 4 Asymptomatic chondrocalcinosis 
Legend: wedge shaped meniscal calcification in the lateral compartment of 
each knee. The patient has no knee pain or radiographic knee osteoarthritis.  
 
Figure 5 Pseudo-neuropathic arthritis 
Legend: attrition, and gross deformity in both knees.  
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1.5.3 European classification 
An important step in simplifying the nomenclature of CPPD was use of the 
WHUP µDFXWH S\URSKRVSKDWH DUWKURSDWK\¶ IRU SVHXGRJRXW DQG µFKURQLF
S\URSKRVSKDWH DUWKURSDWK\¶ IRU WKH FKURQLF DUWKURSDWK\ DVVRFLDWHG ZLWK
CPPD (Currey 1970). At about the same time, Russell et al. used 
µS\URSKRVSKDWH DUWKURSDWK\¶ IRU ERWK && DQG SVHXGRJRXW (Russell et al 
1970). Both nomenclature systems are flawed. While there is no place for 
DV\PSWRPDWLF && LQ &XUUH\¶V V\VWHP 5XVVHOO et al. merged acute and 
chronic arthropathies into one category (Currey 1970; Russell et al 1970). 
7KHUHIRUH 'RKHUW\ DQG 'LHSSH SURSRVHG D PRUH LQFOXVLYH µ(XURSHDQ¶
classification (Doherty et al 1986): 
x chondrocalcinosis - DV\PSWRPDWLF FDOFL¿FDWLRQ RI DUWLFXODU ¿EUR- or 
hyaline cartilage identified by imaging or histology;      
x pyrophosphate arthropathy - structural abnormality of cartilage and 
bone (cartilage loss, osteophyte, cysts ± i.e changes of OA) together 
with any evidence of intra-articular CPP crystal deposition;  
x pseudogout - the clinical syndrome of acute synovitis associated with 
the shedding of intra-articular CPP crystal deposits.  
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1.5.4 EULAR classification 
In order to promote a uniform nomenclature, recently, a EULAR Task Force 
has suggested a simpler terminology and classification system (Zhang W et 
al 2011) (Table 7). 
Table 7 EULAR nomenclature of calcium pyrophosphate deposition 
Calcium pyrophosphate crystal simplified term for calcium pyrophosphate 
dihydrate crystals  
CPP deposition (CPPD)  umbrella term for all instances of occurrence of 
CPP crystals  
Chondrocalcinosis1  cartilage calcification, identified by imaging or on 
histological examination 
Clinical presentations associated with CPPD: 
Asymptomatic CPPD CPPD with no apparent clinical consequence i.e. 
isolated CC 
OA with CPPD CPPD in a joint that also shows changes of 
osteoarthritis (OA), on imaging or histological 
examination  
Acute CPP crystal arthritis acute onset, self-limiting synovitis with CPPD 
(previously pseudogout) 
Chronic CPP crystal inflammatory 
arthritis 
chronic inflammatory arthritis associated with 
CPPD 
1
 This is usually, but not always due to CPPD.      
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1.5.5 Diagnostic criteria 
McCarty defined CPPD as definite, probable or possible depending on the 
clinical features, radiographic and laboratory findings (McCarty 1977) (Table 
8).  
Table 8 McCarty's criteria for calcium pyrophosphate deposition 
1. Demonstration of CPP crystals from joint aspirate or biopsy, by X-ray diffraction pattern 
2. Identification of crystals in synovial fluid showing absent or weakly positive birefringence 
on compound polarized microscopy  
3. Typical radiographic appearance of CC 
4. Clinical features of acute or chronic synovitis 
Definite CPPD 1, or 2 and 3; probable CPPD 2 or 3 
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1.6 Radiographic features 
1.6.1 Radiographic chondrocalcinosis 
On plain radiographs, articular CC is seen as a fine linear calcification of 
hyaline articular cartilage, parallel to and distinct from the underlying articular 
surface, or more commonly as a dense punctate calcification affecting the 
middle layers of the fibrocartilage (Genant 1976) (Figure 1, Figure 3, Figure 
4). This is because CPP crystals deposit preferentially in the middle layer of 
fibro-cartilage and hyaline articular cartilage (Johnson et al 2003; Grassi et al 
2006; Muehleman et al 2008). CC occurs at the articular fibrocartilage more 
often than the hyaline cartilage (McCarty and Haskin 1963; Twigg et al. 
1964; Moskowitz and Katz 1967; Martel et al. 1970; Genant 1976). 
CPPD can also occur in tendons, ligaments, synovial membrane, joint 
capsule bursae, and soft tissues (Genant 1976; Doherty 2003 ) (Figure 1). 
Capsular and tendinous calcifications tend to be linear (Genant 1976). On 
the other hand, synovial CPPD appears as irregular radiodense foci which 
may simulate intra-articular loose body, or synovial osteochondromata 
(Genant 1976). Interestingly, non-articular cartilage CPPD, and some 
synovial membrane CPPD occur in areas of chondroid metaplasia, 
emphasising the importance of a cartilage milieu for CPPD (Ishikawa et al 
1989; Beutler et al 1993; Ishida et al 1995).  
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1.6.2 Joints affected by chondrocalcinosis 
 Early hospital based studies identified the joints affected by CC in 
both sporadic and familial disease (McCarty et al 1963; Zitnan et al 1963; 
Twigg et al 1964; Currey et al 1966; Moskowitz et al 1967; Reginato et al 
1970; Bjelle et al 1974; Resnick et al 1974; Ellman et al 1975) (Table 9). 
These studies demonstrated that CC is usually bilateral and that familial CC 
associates with florid widespread involvement of symphysis pubis, elbow, 
shoulder, MCPJs, and ankle which are less commonly affected in sporadic 
CC (Table 9).  
Table 9 Distribution of calcification in chondrocalcinosis 
Joint Sporadic Familial 
Bilateral Unilateral Bilateral Unilateral 
Knee-meniscus 57-81% 10-36% 77-100% 0-8% 
Knee-hyaline 35-48% 5-22% 63-81% 0-19% 
Wrist 26-50% 5-26% 57-83% 5-19% 
Symphysis pubis 24-44% 89-96% 
Hip 6-44% 5-21% 50-74% 0-6% 
Shoulder 12-34% 0-24% 44-82% 22-82% 
Elbow 12-37% 5-35% 63-84% 15% 
MCP 0-15% 3-17% 11-42% 3-15% 
Ankle 0-7% 0-7% 69-30% 0-4% 
MTP 6-7% 3-12% 22-71% 5-7% 
% of cases with chondrocalcinosis at a particular joint, adapted from Genant 1976. 
Two subsequent hospital based radiographic surveys with 85 
(Resnick et al 1977a), and 105 (Dieppe et al 1982) patients with symptomatic 
CPPD have studied the relative frequency of joints affected by CC (Figure 6). 
Other authors have also reported on the pattern of joints affected by CC in 
hospital based populations (Moskowitz et al 1973; Fam et al 1981; Wilkins et 
al 1983; Gordon et al 1984; Louthrenoo et al 1999; Canhao et al 2001). 
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Figure 6 Frequency of joints affected by chondrocalcinosis in two 
hospital based studies 
0 25 50 75 100
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Hip
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Dieppe et al.
Resnick et al. 
% of cases with chondrocalcinosis who have involvement at a joint  
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1.6.3 Chondrocalcinosis at individual joints 
1.6.3.1 Knee  
The following are the key radiographic appearances of knee CC (Figure 7): 
x predominantly occurs at the fibro-cartilagionous meniscus (McCarty et 
al 1963; Twigg et al 1964; Moskowitz et al 1967; Martel et al 1970; 
Genant 1976) 
o meniscal CC 
 appears as linear or punctate calcification (Genant 1976) 
 may be fine or dense, and commonly produces :  
x a wedge shaped calcification at the medial or 
lateral joint margins (Genant 1976), or  
x a Y shaped radiodensity within the joint, above 
the tibial plate (McCarty et al 1963).  
 more frequent in the lateral than in the medial meniscus 
(Bocher et al 1965; Skinner et al 1969).  
o hyaline articular cartilage calcification appears as a fine linear 
density parallel to the subchondral bone with a radiolucent 
band separating it from the articular cortex (Twigg et al 1964; 
Genant 1976).   
x calcification of the synovial lining of the knee may occur and may be 
pronounced enough to be visible as osteochondromata, which 
commonly occur at the knee (McCarty et al 1963) 
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Figure 7 Knee chondrocalcinosis 
Legend: see description in section 1.5.3.1 in the previous page 
 
1.6.3.2 Wrist and hand 
The following are key features of radiographic appearance of CC at the wrist 
and hand (Figure 8): 
x appearance of fibro- and hyaline cartilage CC is similar to that 
described for the knee (section 1. 5.3.1)   
o triangular fibrocartilage is the preferred site of CC with 70.0% - 
98.0% of affected wrists having calcification at that site (Twigg 
et al 1964; Resnick et al 1974; Resnik et al 1983; Chen et al 
1990; Yang et al 1995; Taniguchi et al 1997; Donich et al 
2000); 
o the luno-triquetral ligament is the second most commonly 
affected site, affecting 54.0% - 77.0% wrists with CC (Yang et 
al 1995; Taniguchi et al 1997);  
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o one study reported a higher prevalence of CC at the luno-
triquetral ligament (77.0%) than at the triangular cartilage 
(74.0%) (Yang et al 1995); 
o other sites commonly affected by CC include the articular disc 
of the inferior radio-ulnar joint (McCarty et al 1963; Genant 
1976) and the radio-carpal joints (Skinner et al 1969); 
o 28.0% of inferior radio-ulnar joints (Yang et al 1995), and 
20.0% - 31.9% of radiocarpal compartments are reported to 
show CC (Resnik et al 1983; Taniguchi et al 1997; Donich et al 
2000); 
o CC may also occur at the midcarpal, trapezio-scaphoid, 
scaphoid-capitate, scapho-lunate, 1st and common 
carpometacarpal joints (Twigg et al 1964; Resnik et al 1983; 
Taniguchi et al 1997; Donich et al 2000).   
 
Figure 8 Wrist chondrocalcinosis 
Legend: calcification of the triangular fibrocartilage in both wrists  
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At the MCPJs, capsular, and synovial calcification are more common than 
cartilage calcification (Genant 1976)( Figure 9).  
 
Figure 9 MCPJ calcification 
Legend: linear capsular calcification (arrow-upper panel), and cloudy 
synovial calcification (arrow-lower panel) 
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1.6.3.3 Pelvis  
The following are the key features of radiographic appearance of CC at the 
pelvis (Figure 10): 
x symphysis pubis calcification appears as a thin linear 
calcification in the middle portion (McCarty et al 1963)  
x at the hip, hyaline cartilage involvement appears as a 
curvilinear calcification parallel to the subchondral bone 
(McCarty et al 1963; Genant 1976)  
x fibrocartilaginous acetabular labrum calcification appears as a 
mottled appearance at the joint margin (McCarty et al 1963; 
Genant 1976). 
 
 
Figure 10 Hip chondrocalcinosis and symphysis pubis calcification 
Legend: mottled acetabular labrum calcification (left panel), thin linear 
calcification in the middle portion of the symphysis pubis (right panel) 
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1.6.3.4 Other sites  
Shoulder: The appearance of CC at the shoulder resembles that at the hip 
(Genant 1976). There may be linear hyaline cartilage calcification (Figure 
11), or spotty calcification of the glenoid labrum. The fibrocartilaginous discs 
of the acromioclavicular and sternoclavicular joints (Twigg et al 1964), and 
the acromioclavicular joint capsule (McCarty et al 1963) may also be 
involved. 
                                                    
 
Elbow: Linear calcification affecting the hyaline cartilage, and the joint 
capsule are common manifestations (Genant 1976). The hyaline cartilage 
calcification may have a triangular appearance in anteroposterior (AP) 
radiographs (Twigg et al 1964). 
Foot and ankle : Calcification of ankle articular cartilage (McCarty et al 1963), 
talonavicular and cuneonavicular (Twigg et al 1964) joints have been 
reported. 
 
Figure 11 Hyaline cartilage calcification at the shoulder 
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Spine: Although based on small hospital based case series, it has been 
suggested that when present spinal CC preferentially occurs in the annulus 
fibrosus (McCarty et al 1963), and it seldom affects the nucleus pulposus 
except in familial CC (Genant 1976) (Figure 12).   
 
 
 
 
 Figure 12 Chondrocalcinosis at the spine 
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1.6.4 Structural changes in joints with chondrocalcinosis 
Although a detailed discussion of OA is not in the scope of this thesis, it is 
necessary to briefly revisit the concept of OA before discussing the 
phenotype of structural changes in joints with CC.  
1.6.4.1 Osteoarthritis 
OA is defined as a usually progressive disease of synovial joints that 
represents failed repair of joint damage which results from stresses that may 
be initiated by an abnormality in any of the synovial joint tissues including 
articular cartilage, subchondral bone, ligaments, menisci, peri-articular 
muscles, peripheral nerves, or the synovium (Lane et al 2011). This process 
may be localised to a single joint, to a few joints or be generalised (Lane et al 
2011).  
The structural changes of OA include joint space narrowing, 
osteophytes, sclerosis, cysts, and attrition. Some patients have no or minimal 
symptoms attributed to OA in the presence of established structural changes 
and vice versa. This suggests that there is an imperfect overlap between the 
disease OA (structural changes visualised on imaging studies), and the 
illness OA (patients reported symptoms of OA) (Lane et al 2011). This 
becomes an important consideration in the definition of OA which can be 
based on the presence of radiographic changes, or symptoms, or both 
symptoms and radiographic changes (Lane et al 2011).  
Any attempt to define OA is further complicated by the fact that 
radiographic techniques have varying sensitivity to demonstrate structural 
changes of OA. Therefore, the population defined as having OA may change 
according to the radiographic technique used. Moreover, the population 
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defined as having OA also depends on the structural radiographic change 
selected to define OA. For example, presence of either osteophytes, joint 
space narrowing, or both may be used to define OA, with implications for the 
population defined as having OA (Altman et al 1995, Kellgren et al 1957). 
Whichever way OA is defined, OA at different joints may be distinct 
conditions rather than a single disease entity (Bierma-Zeinstra et al 2011). 
For example, knee OA, hand OA, and hip OA have differing risk factors, and 
even in one area there is difference between different joints e.g. thumb base 
OA and nodal interphalangeal OA; isolated patello-femoral joint OA and 
multi-compartment knee OA (Bierma-Zeinstra et al 2011). Similarly, OA at a 
joint may occur on the background of a generalised predisposition or be an 
isolated phenomenon, with presence of a generalised predisposition 
suggesting a worse prognosis (Bierma-Zeinstra et al 2011).  
Apart from this, several structural OA subtypes have been described 
e.g. atrophic OA and hypertrophic OA; erosive OA and non-erosive OA; and 
OA with or without radiographic CC (Bierma-Zeinstra et al 2011). It is not yet 
known whether they reflect a continuum of severity or suggest different 
underlying risk factors. Atrophic OA is characterised by severe joint space 
narrowing in the absence of any osteophytosis or with a few small 
osteophytes. On the contrary, hypertrophic OA is characterised by florid 
osteophytosis with less severe joint space narrowing. However, the atrophic 
and hypertrophic OA phenotypes are relatively uncommon especially at the 
knees. In a population based study from Framingham, USA, the atrophic 
phenotype was present in 4.9% knees with radiographic OA, and the 
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hypertrophic phenotype was present in <1.0% knees with radiographic OA 
GHILQHGDV.HOOJUHQDQG/DZUHQFHVFRUH5RHPHUet al 2012).       
1.6.4.2 Phenotype of structural arthropathy associated with chondrocalcinosis 
Early reports of CC were in patients with severe degenerative joint disease 
(McCarty et al 1963; Zitnan et al 1963). For example, in an early report, 14 of 
15 (93%) knee joints with radiographic CC had structural arthropathy, which 
was severe in 4, moderate in 4, and mild in 6 cases (McCarty et al 1963). 
Even in later reports, 11 of 19 (58%) cases with CC had severe structural 
arthropathy at the affected joints (Martel et al 1970). This led to the 
impression that CC associates with severe degenerative arthropathy.  
Also, patients with CPPD + OA were reported to have an unusual 
location of joint involvement compared to those with OA alone. Apart from 
the knee, which is commonly involved in OA with or without co-existent 
CPPD, structural changes were reported to be more common at the MCPJs, 
radio-carpal compartments, trapezio-scaphid joint, shoulder, elbow, and 
ankle in those with CPPD + OA (Figure 13) (Martel et al 1970; Watt 1983). In 
a case control study, 8 of 11 cases with CPPD and structural changes of OA 
had MCPJ arthropathy compared to 1 of 25 cases with OA without CPPD 
(Martel et al 1970). Such an arthropathy predominantly affecting the MCPJs 
and sparing the inter-pahalangeal joints (IPJs) had been previously reported 
in a patient with pseudogout (Janower 1964). 
A few studies have examined the association between CC at any joint, 
and OA at distant joints.   
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x In a hospital based case-control study, patients with CPPD had 
significantly greater overall structural changes at the MCPJs (mean 
(S.D.) score 4.62 (3.53)) than primary OA (mean (S.D.) score 3.60 
(3.29)), p<0.05, Mann-Whitney U test; and had significantly less 
overall structural changes at the trapezio-metacarpal joint (mean 
(S.D.) score 5.39 (5.36)) than primary OA (mean (S.D.) score 7.15 
(5.55)), p<0.03, Mann-Whitney U test (Riestra et al 1985).  
x In another hospital based case control study, wrist arthropathy, and 
MCPJ arthropathy was more common in those with generalised OA 
(GOA ± GHILQHG DV 2$ DW  MRLQWV DQG &33' DW  MRLQWV WKDQ LQ
those with GOA alone (Bourqui et al 1983). 
x ST joint OA without concomitant OA of the 1st CMCJ was reported to 
be common in CPPD (Peter et al 2001). 
x In a community based study, CC predominatly at the knees (96%) 
associated with OA in the 1st - 3rd MCPJs in either hand (age adjusted 
OR (95%CI) 3.1 (1.1-8.8)) (Sanmarti et al 1996). 
x In a primary care based case-control study, CC at the knees (with or 
without wrist CC) increased the risk of OA in the MCPJs and inter-
carpal joints (Al-Arfaj 2002b). The age and gender adjusted ORs (95% 
CI) were 3.27 (1.44-8.93), 6.92 (1.99-25.54) and 5.69 (1.14-29.7) for 
2nd MCPJ, 3rd MCPJ, and inter-carpal joint respectively (Al-Arfaj 
2002b).  
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Therefore, it has been suggested that the presence of CC may alter 
the distribution of OA. This suggests that the occurrence of CC may be 
UHODWHG WR D µJHQHUDOLVHG HIIHFW¶ UDWKHU WKDQ D MRLQW VSHFLILF µORFDO HIIHFW¶
However, the association between CC at one site on OA at distant sites has 
not been examined in a large study.   
 
Figure 13 Radiocarpal and MCPJ arthropathy associated with 
chondrocalcionosis 
Legend: MCPJ narrowing, osteophytes, sclerosis; and wrist sclerosis, cysts, 
attrition associated with MCPJ calcification, and wrist chondrocalcinosis. 
Not only was structural change reported to be common in joints with 
CC, and to be present at different locations than in those with isolated OA, 
joints with CC and and structural arthropathy were reported to have an 
unusual appearance characterised by more subchondral sclerosis (Figure 3), 
marginal osteophytes (Figure 3), and numerous discrete subchondral cysts 
(Figure 13) making them distinct from OA without CC (Martel et al 1970).  
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Several subsequent reports also suggest that the radiographic 
appearance of structural arthropathy associated with CPPD is distinct from 
that of OA without CC (Genant 1976; Resnick et al 1977a; Martel et al 1981). 
According to these reports, the key distinguishing features are:  
1. A different distribution of joint involvement: Along with weight bearing 
joints (e.g. knees), non-weight bearing joints like the glenohumeral, 
wrist, MCP, and elbows joints also had structural changes of OA in 
those with CC (Genant 1976; Resnick et al 1977a; Martel et al 1981).     
2. A different distribution of involved compartments in the affected joints: 
Structural changes of OA were common at the patello-femoral (Figure 
3), radio-carpal (Figure 13), and MCPJ (Figure 13) in those with 
CPPD (Genant 1976; Resnick et al 1977a; Dieppe et al 1982). On the 
contrary, 1st CMCJ involvement was reported to be less common 
(Genant 1976). Structural changes at the patello-femoral joints (PFJs) 
were frequently reported to occur in the absence of any tibio-femoral 
joint (TFJ) involvement (Figure 14) (Dieppe et al 1982). 
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Figure 14 Patello-femoral joint osteoarthritis associated with knee 
chondrocalcinosis 
Legend: Left knee CC, with isolated patella-femoral joint OA 
3. Frequent subchondral cysts with CPPD: The subchondral cysts noted 
were multiple, large, present at many joint sites, and usually had 
sclerotic margins (Figure 15) (Resnick et al 1977a,b; Martel et al 
1981; Watt 1983). In some instances, the subchondral cysts were 
DUUDQJHGLQDµVWULQJRIEHDGVSDWWHUQ¶(Martel et al 1981). Subchondral 
sclerosis was also reported to be common (Dieppe et al 1982). 
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Figure 15 Subchondral cyst in hip osteoarthritis associated with 
chondrocalcinosis at distant joints 
4. Severe joint destruction manifesting as:  
a. Rapidly evolving suchondral erosive arthropathy affecting both 
weight bearing, and non-weight bearing joints (Genant 1976). 
b. Fragmentation of subchondral bone (Genant 1976), with 
collapse of articular surfaces (Martel et al 1981), resulting in the 
formation of intra-articular loose bodies which may mimic 
neuropathic arthropathy without any gross neurological 
involvement ± the so called pseudo-neuropathic arthropathy 
(Resnick et al 1977a; McCarty et al 1963; Watt 1983) (Figure 
16).  
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Figure 16 Rapidly progressive destructive arthropathy associated with 
hip chondrocalcinosis 
Pseudo-neuropathic arthropathy was first reported by McCarthy et al in 1963, 
and reported to affect both non-weight bearing, and weight bearing joints. It 
was reported to lead to pronounced joint destruction over a relatively short 
period of time. Several subsequent hospital based case series suggested 
that such an arthropathy is common in patients with CPPD + OA at the knee 
or the hip (Genant 1976; Fam et al 1981; Martel et al 1981). However, 
Dieppe et al were unable to separate pseudo-neuropathic arthropathy as a 
distinct person specific clinical entity in a larger case series of over 100 
patients with CPPD + OA (Dieppe et al 1982).  
The pathophysiology of this condition is not well understood. Local joint 
instability has been proposed to precede the pseudo-neuropathic 
arthropathy, with the instability resulting in mechanical damage and crystal 
deposition (Dieppe et al 1982).   
5. Variable osteophytosis: In some patients, irregular large bony 
excrescences were present (Figure 17, Figure 18) (Dieppe et al 
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1982), while in others joint space narrowing, subchondral sclerosis, 
and bony fragmentation occured with minimal or no osteophytosis 
(Figure 16) (Resnick et al 1977a; Watt et al 1983a). However, different 
radiographic phenotypes can be present in the same person (Figure 
18).   
 
Figure 17 Knee chondrocalcinosis with osteophytosis and joint space 
narrowing   
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Figure 18 Knee chondrocalcinosis with marked joint space narrowing 
and minimal osteophytosis 
Legend: Right knee: joint space narrowing without osteophytes. Left knee: 
joint space narrowing, remodelling, subchondral sclerosis, and marked 
osteophytes 
The association between CC and structural change seems to be at least 
in part a joint specific phenomenon. For example, in those with knee CC, the 
additional presence of wrist CC associates with structural arthropathy at the 
wrist (Taniguchi et al 1997).  
CC at knees, hips or symphysis pubis may associate with more severe 
global structural changes of OA at knees but not at hips (Musacchio et al 
2011). In a recent large case-control study of healthy community dwelling 
older people from Southern Italy, participants with CC at knees, hips or 
symphysis pubis had a greater summated global knee OA radiographic 
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severity score than those without CC (Musacchio et al 2011). In this study, 
right and left knees were analysed separately and osteophytosis, joint space 
narrowing, subchondral sclerosis and malalignment at the TFJs were 
summated to yield a global radiographic features score ranging from 0-24 for 
each knee (Musacchio et al 2011). The mean radiographic features score at 
the knees were: right knee 5.7 when CC was present, and 3.8 when CC was 
absent (age-adjusted p<0.0001); and left knee 5.1 when CC was present 
and 3.4 when CC was absent (age-adjusted p<0.0001) (Musacchio et al 
2011). The differences were still statistically significant when the population 
was stratified by gender (age-adjusted p=0.003) (Musacchio et al 2011). 
Interestingly, the radiographic features score was worse in the right knee 
than in the left knee both for participants with and without CC (p=0.001) 
(Musacchio et al 2011).  
As shown previously, there appears to be no association between CC 
and the severity of radiographic features at either hip. The mean 
radiographic features score at the hips were: right hip 2.5 when CC was 
present, and 2.2 when CC was absent (p>0.05); and left hip 2.6 when CC 
was present, and 2.3 when CC was absent (p>0.05) (Musacchio et al 2011).  
An analysis of association between CC and OA at the same joint was not 
carried out in this study. However, the greater knee OA radiographic features 
score in those with CC reported in this study could be explained by the 
association between CC and knee OA, and the lack of association between 
CC and hip OA.  
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Nevertheless, not all studies support the view that CC associates with a 
different OA phenotype. 
x In a hospital based case control study of 21 cases with knee OA and 
CC, and 21 age matched controls with knee OA alone, osteophytosis, 
joint space narrowing, subchondral sclerosis, and subchondral cysts 
were no more common in knee joints with CC + OA than in knee joints 
with OA alone (Hansen et al 1984). However, according to this study, 
joints with CC + OA were more likely to have condylar flattening, 
anterior femoral cortical erosion, and supra-patellar effusion (Hansen 
et al 1984).  
x Similarly, in a hospital based study of 74 symptomatic CPPD cases, 
and 68 age and gender matched OA controls, CPPD did not associate 
with greater overall radiographic scores (Riestra et al 1985).  
o In this study, the mean (S.D) overall summated score of 
individual radiographic changes of OA was 4.48 (4.66) in those 
with CPPD, and 4.31 (3.21) in those with OA alone, p>0.05 
(Riestra et al 1985).  
o Severe lower limb arthropathy was no more common in those 
with CPPD than in those with OA alone, occurring in 5 patients 
with CPPD, and in 4 patients with OA alone (Riestra et al 
1985).  
o Also, there was no difference in the overall severity of joint 
space narrowing in those with CPPD and in those with OA 
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alone except at the trapezio-metacarpal joint where participants 
with CPPD had less severe joint space narrowing than those 
with primary OA (Riestra et al 1985). The mean grade of joint 
space narrowing at the trapezio-metacarpal joint in those with 
CPPD was 2.00 (1.83), whereas the mean grade of joint space 
narrowing in those with primary OA alone was 2.63 (1.73), 
p<0.035 (Riestra et al 1985).  
 
Figure 19 Wrist chondrocalcinosis with trapezio-scaphoid arthropathy 
Legend: Trapezio-scaphoid arthropathy (sclerosis and joint space narrowing) 
with relative sparing of the trapezio-metacarpal joint associated with bilateral 
wrist chondrocalcinosis. 
x In a prospective study, the presence of CPP crystals did not associate 
with progressive joint space loss, osteophytosis, sclerosis and cyst 
formation in those with knee OA observed for 2 years (Ledingham et 
al 1995).  
x In a community based prospective study with follow-up of between 15 
months to 3 years, the presence of knee CC was shown to protect 
against or to have no effect on progressive joint space loss in 
community dwelling adults with symptomatic radiographic knee OA 
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((aRR (95%CI)) 0.4 (0.2-0.7) Boston OA Knee study and 0.9 (0.6-1.5)) 
Health ABC Study) (Neogi et al 2006).  
  One study suggests that the greater osteophytosis and more severe 
joint space narrowing observed in joints with CPPD is limited to joints with 
co-existent CPP and BCP crystals (Halverson et al 1986). In this case control 
study of patients presenting to a rheumatology clinic with knee pain, the 
extent of knee OA changes correlated with the presence of BCP crystals. In 
joints with no crystals in the synovial fluid aspirate and in joints with CPP 
crystals alone, the prevalence of three compartment osteophytosis was 
26.3% and 12.5% respectively, whereas joints with BCP crystals alone or 
joints with co-existent BCP and CPP crystals had a higher prevalence of 
three compartment osteophytosis ± 78.6% and 72.2% respectively. In this 
study, none of the joints with BCP crystals alone had CC, while CC was 
present in 87.5% of patients with CPP alone and in 77.8% of patients with 
both CPP and BCPcrystals (Halverson et al 1986). However, this reported 
association between OA and BCP crystals may be due to the fact that intra-
articular BCP crystal deposition is integral to the development of end-stage 
OA (Fuerst et al 2009a; Fuerst et al 2009b). 
In summary, the published evidence to date does not convincingly 
support or refute the notion that CPPD associates with a specific 
radiographic phenotype which is distinct from that observed in OA alone at 
any joint.        
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1.6.4.2 Chondrocalcinosis and joint destruction  
Apart from the three studies discussed previously (Genant 1976; Resnick et 
al 1977a; Martel et al 1981), other hospital based studies also suggest that 
CC associates with a rapidly destructive arthropathy (Figure 3, Figure 
5,Figure 20).  
 
Figure 20  Destructive arthropathy associated with chondrocalcinosis 
For example, in those with GOA, CC was reported to associate with 
destructive arthropathy at large joints.  
o In a case control study, 46.4% participants with GOA (defined 
DV2$DW MRLQWVDQG&&DW MRLQWV DQGSDUWLFLSDQWV
with GOA alone had large joint destructive arthropathy 
(p<0.001) (Gerster et al 1975a). In another case control study, 
SDUWLFLSDQWVZLWK*2$GHILQHGDV2$DW MRLQWVDQG
CC at 2 joints, and 7.5% participants with GOA alone had large 
joint destructive arthropathy (p<0.01) (Gerster et al 1975b). 
Non weight-bearing joints like shoulders, elbows and wrists 
also showed changes of joint destruction (Gerster et al 1975b).  
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Similarly, in a hospital based study, CC was reported to associate with 
rapidly progressive OA.  
o 28 of 86 hip OA patients with rapid destruction (>10mm upward 
migration of femur over 1 year) and 16 of 86 hip OA patients 
without rapid destruction of the hip had CC at 2 joint sites 
(p<0.05) (Menkes et al 1985). 
Also, CPP crystals were reported to associate with attrition in knee OA 
(Figure 3, Figure 5, Figure 20).  
o CPP crystals associate with attrition in knee OA over a 2 year 
period (aOR (95%CI) : 2.41 (1.33-4.39)) (Ledingham et al 
1995). 
Several other reports also suggest that there is a high prevalence of 
destructive arthropathy in those with structural arthropathy and CPPD.  
o 6.3% (5/80) patients with idiopathic CPPD seen at a single 
hospital had destructive arthropathy at the hips, knees, spine, 
hands, and shoulders (Richards et al 1974) (Figure 20).  
o 13.5% (15/113) patients with CC diagnosed over 3 years had 
destructive arthropathy (Menkes et al 1976). Destructive 
arthropathy was more common in women, and in the elderly 
(Menkes et al 1976). 
o   SDWLHQWV ZLWK µSVHXGRJRXW¶ KDG GHVWUXFWLYH 2$
changes, with large subchondral bony cysts, subchondral 
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collapse and fragmentation, large osteophytes, and intra-
articular osteochondromata (Fam et al 1981). (Figure 20, Figure 
3) 
o Three cases with destructive wrist arthropathy in patients 
presenting with acute CPP crystal arthritis were reported 
(Smathers et al 1982). 
A high proportion of patients with CC and destructive arthropathy have 
been reported to have destruction of non-weight bearing joints. For example, 
of the 15 patients with CC and destructive arthropathy destructive changes 
were seen in knees, shoulders, hips, and wrists in 12, 12, 7, and 4 
participants respectively (Menkes et al 1976). Similarly, of the five patients 
with idiopathic CPPD and destructive arthropathy, destructive changes were 
present at the shoulders, and wrists in 2 patients each (Richards et al 1974).  
However, other case-control studies do not show any association 
between CPPD and more severe arthropathy (Riestra et al 1985). Similarly, 
the two studies to prospectively examine the association between knee CC 
and radiographic progression of knee OA did not find any convincing 
evidence of association between CC and progressive joint space loss 
(Ledingham et al 1995; Neogi et al 2006). One of these studies also reported 
a lack of association between knee CC at baseline, and progressive 
osteophytosis, sclerosis, and cyst formation in knee OA (Ledingham et al 
1995). These studies suggest that although a subset of OA patients with CC 
have destructive arthropathy, but CC in itself does not worsen the outcome 
of OA. 
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1.6.5 Radiographic phenotype of osteoarthritis in joints with chondrocalcinosis  
1.6.5.1 Knee  
Number of compartments affected by structural arthropathy: 
Only a few studies have examined the number of knee compartments with 
structural changes in those with CPPD + knee OA compared to knee OA 
alone. In a hospital based cross-sectional study of symptomatic knee OA, the 
presence of CPP crystals associated with multi-compartment knee OA (aOR 
(95%CI) 3.31 (1.61-6.77)) (Ledingham et al 1993a), and with bi- or tri-
compartmental involvement (Pattrick et al 1993), but not with uni-
compartmental OA (Pattrick et al 1993).  
However, not all studies report that knee CC associates with structural 
changes in multiple knee compartments. For instance, in a hospital based 
case control study, tri-compartmental structural changes were significantly 
less common in knees with CPPD + OA than in knees with OA alone 
(Resnick et al 1977a). Similarly, in a hospital based case series of 50 cases 
of knee OA + CPPD, 70.7% of knees had uni-compartmental OA, 25.9% had 
bi-compartmental OA, and tri-compartmental OA changes were particularly 
rare, occurring in only 2 (3.4%) knees (Bjelle et al 1974).  
Location of knee compartment affected by structural changes in CPPD 
Several studies have examined the compartmental location of structural 
changes in knees with OA + CPPD. Early studies suggested that structural 
changes are more common at the PFJs than at the TFJs. 
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x In a hospital based study of 50 cases with knee CC plus OA, OA 
changes were more common in the PFJs (62.1%) than in the medial 
TFJ compartment (51.7%) (Bjelle et al 1974). However, isolated PFJ 
OA (36.2%) was only slightly more common than medial compartment 
TFJ OA (34.5%) (Bjelle et al 1974).  
x In another hospital based case control study, isolated PFJ OA was 
more common in joints with CPPD + OA than in joints with OA alone 
(Resnick et al 1977a). Isolated PFJ OA occurred in 47 of 116 knees 
with CPPD and knee OA, compared to 4 of 52 knees with knee OA 
alone (Resnick et al 1977a). Isolated PFJ OA was significantly more 
common than medial TFJ OA in those with CPPD plus OA at the knee 
(Resnick et al 1977a) (Figure 14). 
Several subsequent studies have examined the compartmental 
localization of OA in knees with CPPD (Table 10). A predisposition to 
involvement of any knee compartment was not observed in two case control 
studies (Hansen et al 1984; Riestra et al 1985), and in one cross-sectional 
study (Neame et al 2003), whereas another cross sectional study reported 
that TFJ OA, but not PFJ OA associates with knee CC (Ledingham et al 
1993a). Also, in a cross-sectional study examining the risk factors for TFJ 
and PFJ OA, the prevalence of CC in isolated TFJ OA, isolated PFJ OA, and 
combined TFJ and PFJ OA was similar i.e. 17.9%, 21.9%, and 20.0% 
respectively (McAlindon et al 1996).  
Some studies suggested that knee CC associates with structural 
changes in the lateral TFJ compartment. In a cross-sectional study, knee CC 
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associated with osteophytosis in the lateral aspect of the knee joint, that is 
osteophytes in the lateral femur, lateral tibia, lateral patella and lateral 
trochlea (aOR (95%CI) 4.38 (1.45-13.2), 28.6 (3.69-221.9), 2.77 (1.09-7.04) 
and 4.71 (1.85-12.0) respectively) (Nagaosa et al 2002) but not with 
osteophytosis in the medial aspect of the knee joint.  In a primary care based 
case-control study, presence of CC at the knees (with or without wrist CC) 
increased the risk of OA in the lateral tibio-femoral compartment of the knee 
(Al-Arfaj 2002b) (Figure 21). The age and gender adjusted OR (95% CI) was 
10.59 (3.47-34.9) (Al-Arfaj 2002b). However, such a predisposition has not 
been reported in two other studies (Ledingham et al 1993a; Sanmarti et al 
1996). Therefore, based on the published literature, no firm conclusion can 
be drawn as to whether any particular knee compartment is affected more 
frequently in those with CPPD + OA at the knee.  
 
Figure 21 Atrophic lateral tibio-femoral compartment osteoarthritis 
associated with knee chondrocalcinosis 
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Table 10 Association between chondrocalcinosis and compartmental 
location of knee osteoarthritis 
Study Study 
design 
Lateral TFJ  Medial TFJ  PFJ 
Neame et al 
2003 
Cross 
sectional 
2.00 (1.11-3.60)1 2.08 (1.38-3.12)1 
Ledingham et al 
1993a 
Cross 
sectional  
6.19 (3.03-12.6) 2 7.07 (1.41-35.4)2 No association2 
Sanmarti et al 
1996 
Case 
control  
5.50 (2.00-14.90) 1 1.90 (0.70-5.00)1 Not studied 
Hansen et al 
1984 
Case-
control  
No association3 No association3 
Riestra et al 
1985 
Case-
control 
No difference in severity of joint space 
narrowing between two compartments 
Not studied 
aOR (95%CI) adjusted for age and gender
1
,
 
age and BMI
2
 and age
3
 respectively.  
Individual structural changes in knee joints with OA+ CPPD 
At the knee, CPPD has been variously associated with greater 
osteophytosis, sclerosis, attrition and cystic change (Ledingham et al 1993a; 
Pattrick et al 1993; Neame et al 2003), but not with joint space narrowing 
(Ellman et al 1981b; Ledingham et al 1993a; Neame et al 2003). 
Other specific radiographic phenotypes reported to associate with 
CPPD at the knee include: 
x femoral condylar flattening (Hansen et al 1984) 
x anterior femoral cortical erosion (Lagier 1974; Hansen et al 
1984)  
x suprapatellar effusion (Hansen et al 1984) 
x femoral condyle osteonecrosis with a predisposition for the 
medial femoral condyle (Watt et al 1983b; Kwak et al 1999) 
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x cystic change in the head of fibula (Ledingham et al 1993b) 
x tibial stress fractures (Ross et al 1983) 
However, in one study of symptomatic radiographic knee OA, anterior 
femoral cortical erosions were found to be no more frequent in joints with 
CPP crystals than in joints without CPP crystals (Pattrick et al 1993).  
1.6.5.2 Wrist  
In wrists with OA + CPPD, structural arthropathy occurs at the radio-carpal, 
mid-carpal and common carpo-metacarpal joints (between the proximal end 
of the 2nd to 4th metacarpal bones and the distal row of carpal bones) in a 
descending order of frequency (Figure 13, Figure 19) (Resnick et al 1974). In 
fact, mid-carpal involvement is reported not to occur in the absence of radio-
carpal involvement, and common carpo-metacarpal involvement is rare 
(Resnick et al 1974). Similar findings were reported in a study of 102 wrists 
from 51 patients with probable or definite CPPD at any site (Resnik et al 
1983). Structural arthropathy manifesting as joint space narrowing was 
present in 21% radio-carpal, 16% trapezio-scaphoid (ST), and 14% other 
midcarpal (except ST) joints, and was absent at the common CMCJ (Resnik 
et al 1983) (Figure 13, Figure 19). Structural arthropathy was most common 
at the radio-scaphoid, radio-lunate, and ST joints (Resnick et al 1974; Resnik 
et al 1983) (Figure 13, Figure 19).  However, these studies are limited by the 
lack of a control group. 
Subtle changes in location of structural arthropathy at the wrist in 
those with OA + CPPD has been reported when compared to OA alone. Of 
note, patients with CPPD are reported to have a predilection for the structural 
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changes to occur at the ST joints and to spare the trapezio-metacarpal joint 
(Figure 19). This is based on following studies: 
x The mean (S.D.) OA grade at the ST joint in CPPD + OA was higher 
than that in OA alone (2.63 (1.83), compared to 2.63 (1.73); p<0.035, 
Mann-Whitney U test) (Riestra et al 1985). 
x  In a hospital based case control study of cases with CPPD at any 
site, and controls with hand OA (IPJ or 1st CMCJ OA), the presence of 
JUDGH  67- 2$ DVVRFLDWHG ZLWK &33' D25 &,  -
59.8) (Stucki et al 1999).  
x In a hospital based case control study of 50 patients with CC and 100 
age matched controls, STJ arthropathy was observed in 28% cases 
compared to 5% controls (Bensasson et al 1976). Moreover, STJ 
arthropathy in the absence of 1st CMCJ involvement occurred in 16% 
of CC cases and did not occur in any controls (Bensasson et al 1976). 
x Similarly, in a hospital based case control study of 160 participants 
with wrist CC, and 160 age and gender matched controls, STJ 
arthropathy was present in 43.7% of CPPD wrists, and in 14.4% of 
control wrists (Donich et al 2000).  
x The association between STJ OA and CPPD has been reported in 
another hospital-based study (Peter et al 2001). In this study structural 
FKDQJHVLQWKH67-ZHUHGHVFULEHGDVµDWURSKLF¶ZLWKDSUHGRPLQDQFH
of joint space narrowing and subchondral sclerosis but with little or no 
osteophytosis (Peter et al 2001).  
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However, a hospital based case-control study of 46 patients with GOA (OA 
DWMRLQWVDQG&33'DWMRLQWVDQGZLWK*2$DORQHGLGQRWILQGDQ
association between CC and STJ OA (Bourqui et al 1983). 
Radiographic structural abnormalities reported to be common in wrists 
with CC at the index or distant joints include joint space loss, sclerosis, and 
cysts (Resnick et al 1974) (Figure 13, Figure 19). The joint space narrowing 
is reported to occur predominantly in the radio-carpal joint, particularly at the 
radio-scaphoid, and to a lesser extent at the radio-lunate joints (Resnick et al 
1974). Sclerosis is most prominent in the scaphoid and lunate (Resnick et al 
1974). Subchondral cysts are marginal, eccentric, with a sclerotic margin, 
and at the wrist are most common in the proximal carpal row, notably in the 
scaphoid, lunate and capitate (Resnick et al 1974; Donich et al 2000). 
Patients with CPPD plus OA have more subchondral cysts at the wrist 
compared to patients with OA without CPPD (mean (S.D.) grade 1.43 (1.94) 
versus 0.85 (1.78) in primary OA; p<0.01, Mann-Whitney U test) (Riestra et 
al 1985). Subchondral cysts with or without joint space narrowing were also 
significantly more common in those with CPPD and GOA than in those with 
GOA alone (Bourqui et al 1983). These were sometimes, but not always, 
associated with joint space narrowing (Bourqui et al 1983).    
Scapho-lunate dissociation and a radiographic appearance similar to 
scapho- lunate advanced collapse (SLAC) may also associate with wrist CC 
(Resnick et al 1974; Resnick et al 1977a; Donich et al 2000). SLAC 
comprises joint space narrowing at the radio-scaphoid and capito-lunate 
joints with relative sparing of the luno-radial joint together with scapho-lunate 
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dissociation (horizontal distance at midpoint of scapho-lunate joint >2mm) 
(Resnick 1985) (Figure 22). In a hospital based case-control study of 160 
wrists with CC, and 160 age and sex matched control wrists, SLAC was 
present in 5.9% of the CPPD wrists, and in none of the control wrists (Donich 
et al 2000). SLAC was reported in 9.0 - 21.0% of CPPD wrists (Resnik et al 
1983; Chen et al 1990) and was present in 12 patients presenting with acute 
CPP crystal arthritis (Doherty et al 1993).   
 
Figure 22 Scapholunate advanced collapse associated with wrist 
chondrocalcinosis 
It is possible that SLAC wrist associates with CC at any site and is not 
a direct association of wrist CC. For example, in a hospital based case-
control study from Japan, the overall prevalence of SLAC wrist in those with 
CC at any site (knee or wrist) was 4.7% (Taniguchi et al 1997). In these 
patients, the prevalence of SLAC wrist was comparable in those with (5.0%) 
or without (4.3%) wrist CC (Taniguchi et al 1997).  
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1.6.5.3 Hand   
In CPPD structural changes are common at the MCPJs (Resnick et al 1974). 
The structural changes are reported to be more frequent at the MCPJs than 
at the wrist (Adamson et al 1983; Resnik et al 1983), and in one study 
structural changes were rare at the wrist in the absence of MCPJ arthropathy 
(Adamson et al 1983) (Figure 23).  
 
Figure 23 MCPJ osteoarthritis associated with wrist chondrocalcinosis 
Legend: Note the relative sparing of the radio-carpal joint. The trapezio-
scaphoid joint shows sclerosis and loss of joint space.  
The second and third MCPJs are most frequently affected with 
structural arthropathy (Resnick et al 1974; Adamson et al 1983; Bourqui et al 
1983; Sanmarti et al 1996) (Figure 23, Figure 24). Patients with CPPD plus 
MCPJ OA have been variously reported to have severe subchondral 
sclerosis, multiple cysts, joint space narrowing, and florid osteophytosis at 
the MCPJs (Resnick et al 1974; Adamson et al 1983; Resnik et al 1983). 
Although exuberant osteophyte formation creating hook like excrescences on 
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the radial aspects of the metacarpal heads is associated with 
haemochromatotic arthropathy, these changes have been reported to also 
occur in joints with idiopathic CPPD plus OA (Adamson et al 1983).  
 
Figure 24 MCPJ osteoarthritis associated with chondrocalcinosis  
Legend: MCPJ OA associated with MCPJ calcification. Note involvement of 
the 2nd and 3rd MCPJs, and sparing of the 4th and 5th MCPJs. 
However, these observations are based on hospital based case 
series, and frequently lack a control group. In a hospital based case-control 
study, hand x-UD\VRISDWLHQWVZLWK&33'DWMRLQWVDQG*2$GHILQHG
DV UDGLRJUDSKLF 2$ DW  MRLQWV ZHUH FRPSDUHG ZLWK KDQG [-rays of 46 
patients with GOA alone (Bourqui et al 1983). In this study, the additional 
presence of CPPD in those with GOA associated with subchondral cysts in 
the metacarpal head, and with MCPJ axis deviation, but did not associate 
with osteophytosis or joint space narrowing (Bourqui et al 1983).  
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Finger IPJ OA was reported to be common in early hospital based 
case series of CPPD patients (Resnick et al 1974). This is not surprising, as 
patients with structural arthropathy and symptoms are likely to be over-
represented in such hospital based case series (Figure 25). However, since 
then, structural changes at IPJs have been shown to either associate 
negatively with, or have no association with CPPD. This is supported by 
findings from one case series (Adamson et al 1983), and several case-
control studies (Bourqui et al 1983; Ledingham et al 1993a). Similarly, in a 
community based cross-sectional study, there was no association between 
knee CC and finger nodes ± which are a marker of underlying IPJ OA (Rees 
et al 2012) - 40.6% of those with knee CC had finger nodes, compared to 
35.1% of those without CC (p=0.38) (Neame et al 2003).  
 
Figure 25 MCPJ osteoarthritis associated with knee chondrocalcinosis  
Legend: Note severe MCPJ OA associated with knee CC. There are OA 
changes at the IPJs, and 1st CMCJs, suggesting the presence of GOA. 
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1.6.5.4 Hip 
As mentioned before, CC is uncommon at the hips. There are only a few 
studies of structural changes associated with CC at the hip. In a post-mortem 
study of 8 hips with OA + CPPD and 42 hips with OA alone, Resnick et al 
reported on the universal presence oIPXOWLSOH µJHRGHV¶ LQ MRLQWVZLWK2$
CPPD while joints with OA alone sometimes had single cysts (Resnick et al 
1977c). This study raises the possibility that in those with hip OA + CPPD, 
cysts would be more common than in hips with OA alone (Figure 26). 
However, in a hospital based nested case-control study, there was no 
association between subchondral cyst and hip CC (Ledingham et al 1992). 
  
Figure 26 Hip osteoarthritis with multiple cysts, subchondral sclerosis, 
and osteophytosis associated with knee chondrocalcinosis 
Also, there was no association between the pattern of migration of 
femoral head, attrition, osteophytes and CC at any hip (Ledingham et al 
1992). In another study, hips of patients with CPPD were significantly more 
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likely to have axial migration compared to hips with OA alone (Resnick et al 
1977a,b) (Figure 27).  
 
Figure 27 Atrophic hip osteoarthritis associated with hip 
chondrocalcinosis  
Legend: Atrophic hip OA (left hip), chondrocalcinosis in the acetabular 
labrum at the right hip.  
In a hospital based case-control study, hips with OA + CPPD had a 
milder OA phenotype (Resnick et al 1977a). In this study, there was a 
negative association between joint space narrowing in those with CPPD plus 
hip OA compared to hip OA alone. Joint space narrowing was present in 
29.0% of hips with CPPD and OA and in all hips with OA alone. However, 
according to this study, hip CC associates with an atrophic bone response in 
hips with OA (Ledingham et al 1992) (Figure 27). 
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1.6.6. Peri-articular calcification  
1.6.6.1 Tendon calcification 
Ill-defined tendinous calcifications were first described in patients with CC by 
McCarty et al. (McCarty et al 1963). In a hospital based case series, 9 of 19 
(Martel et al 1970), and 7 of 40 (Martel et al 1981) CPPD cases had tendon 
calcification. This was reported to be bilateral (Martel et al 1970), and to 
extend far from the tendon attachments (Martel et al 1981). The common 
sites of involvement were the tendo achilles, gastrocenmius, triceps, and 
supraspinatus tendons (Martel et al 1970; Martel et al 1981). Tendinous 
calcifications asociated with CPPD is frequently linear and extensive 
compared to the more discrete and focal periarticular calcification seen with 
BCP (mainly hydroxyapatite) deposition  (Watt 1983) (Figure 28).  
 
Figure 28 Tendon and soft-tissue calcification 
In those with CC, tendon calcification associates with increasing age, 
female gender, widespread, and dense knee CC (Kanterewicz et al 1993). 
Tendon calcification in CC is generally asymptomatic. However, 3 of 10 
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cases with CC and Achilles tendon calcification developed acute attacks of 
tendinitis (Gerster et al 1980). An age matched case-control study showed 
tendon calcification to be more frequent in those with CC and GOA than in 
GOA alone (Gerster et al 1977). Thirteen percent of cases with CC and GOA 
had tendon calcifications compared to none of the 52 cases with GOA alone 
(Gerster et al 1977). In another study, 30% of those with CC and OA had 
tendon calcification compared to 3.3% age and gender matched controls 
(Gerster et al 1984). In a hospital based case control study, tendo achilles 
calcification on US was more common in those with chondrocalcinosis than 
in those with OA, or healthy controls (57.9% vs. 0%) (Falsetti et al 2004). In 
the same study, plantar fascia calcification was more common in those with 
CC, than in those with OA alone (15.8% vs. 2%) (Falsetti et al 2004). Similar 
prevalence of tendo achilles and plantar fascia calcification were reported in 
a recent study (Ellabban et al 2012).     
Table 11 Prevalence of tendon calcification in chondrocalcinosis 
Study Population X-ray  Gastrocnemius Quadriceps Achilles Others 
Yang et al 
1996 
Radiology 
files 
Knee 31.9% 10.1% -/- -/- 
Foldes et al 
1996 
Knee pain  Knee 40.5% Not  
reported 
-/- -/- 
Pereira et al 
1998 
Radiology 
files 
All 
available 
20.5% 21.0% 25.5% Elbow13.8%, 
rotator-cuff 
12.1% 
Falsetti et al 
2004 
Hospital 
based 
Feet -/- -/- 52.6%1 Plantar 
fascia 15.8% 
Kanterewicz 
et al 1993 
Case 
series  
Pelvis -/- -/- -/- Hip adductor 
25.3% 
Gerster et 
al 1977 
Hospital 
based 
Feet and 
knee 
None 13.5% 13.5% Plantar 
fascia 1.9% 
130 of 57 cases on x-ray, 3 more cases identified on heel ultrasound. 
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1.6.6.2 Tophaceous calcium pyrophosphate deposition  
Peri-articular or intra-articular CPPD may enlarge and present as a 
VXEFXWHQRXVPDVVRUµWRSKXV¶(Ling et al 1982). Tophaceous CPPD was first 
reported near an IPJ in a dog (Gibson et al 1972). Similar tumoral calcified 
masses have been reported at the temporomandibular joint (Pritzker et al 
1976), IPJ (Leisen et al 1980), and MCPJ (Ling et al 1982) in humans. 
Tophaceous CPPD occurs in localised areas of chondroid metaplasia, and 
does not associate with CC or with destructive arthropathy at other joints 
(Ling et al 1982). 
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1. 7 Pathogenesis 
1.7.1 Determinants of calcium pyrophosphate crystal formation    
   
CPP crystals form extracellularly, either in the pericellular cartilage matrix, or 
in the enzyme rich membrane bound extracellular organelles - the articular 
cartilage vesicles (ACVs) (Pritzker et al 1988; Derfus et al 1992; Ryan et al 
1995). Although calcium is a constituent of CPP crystals, high calcium 
concentration alone has not been shown to increase CPP crystal formation 
(Mandel et al 1984). However, high extracellular pyrophosphate (ePPi) 
concentration appears to be a key determinant of CPP crystal formation 
(Ryan et al 1995; Terkeltaub 2001). Synovial fluid PPi is higher in joints with 
CPP crystals than in those with OA without CPPD, gout or rheumatoid 
arthritis (Altman et al 1973; Doherty et al 1996). This is a local abnormality as 
the plasma and urine concentrations of PPi are not raised (Pflug et al 1969; 
Russell et al 1970; Altman et al 1973). CPPD is also facilitated by nucleating 
factors and cartilage matrix changes which promote crystal nucleation and 
growth (Ishikawa et al 1989; Doherty 2003 ).   
 As PPi is not absorbed from the gut, nearly all PPi is produced 
endogenously mainly by nucleotide tri-phosphate (NTP) hydrolysis (Russell 
1976). PPi is also released during synthesis of proteins, lipids, phospholipids, 
nucleotides, glycogen, and polysaccharides (Russell 1976). In adults, several 
kilograms of PPi is estimated to be produced per day (Russell 1976). 
However, the majority of PPi is rapidly hydrolyzed to phosphate (Pi) 
releasing 6.6 kcal/mmol (Russell 1976; Murray RK 1996).  
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1.7.2 Pyrophosphate concentration and type of crystal formed  
PPi concentration regulates whether CPP or BCP crystals are formed. High 
PPi concentration promotes CPP crystal formation, and inhibits 
hydroxyapatite and other BCP crystal nucleation and growth, while lower PPi 
levels promote hydroxyapatite crystal formation (Cheng et al 1983; 
Thouverey et al 2009). In fact it is the Pi/PPi ratio that is critical to the type of 
crystal formed. In a chicken embryo growth plate matrix vesicle (MV) model, 
CPP crystals formed exclusively when the Pi/PPi ratio was <6, and 
hydroxyapatite crystals were produced optimally when the Pi/PPi ratio was 
>140 (Thouverey et al 2009). The formation of hydroxyapatite crystals was 
completely inhibited when the Pi/PPi ratio was <70, and the formation of CPP 
crystals was inhibited when this ratio was >28.4 (Thouverey et al 2009).  
1.7.3 Pyrophosphate metabolism         
Synovial fluid PPi is produced by both fibro- and hyaline articular cartilage 
chondrocytes (Ryan et al 1981). Some periarticular structures like tendon 
and ligaments release smaller amounts of PPi (Rosenthal et al 1993). Since 
PPi cannot diffuse across plasma membranes, synovial fluid PPi mainly 
originates from:   
[1] pyrophosphohydrolysis of the phosphodiesterase I bond in the synovial 
fluid (extracellular) nucleotide tri-phosphate (NTP) by NTP 
pyrophosphohydrolase (NTPPPH) enzyme plasma cell glycoprotein 1 (PC1 ± 
also called ENPP1) situated on the plasma membrane or in extracellular 
ACVs (Derfus et al 1992; Johnson et al 2001), or 
104 
 
 [2] transport of intracellular PPi across the plasma membrane by ANKH 
(ankylosis human) a multipass transmembrane protein (Pendleton et al 2002; 
Gurley et al 2006) (Figure 29).   
The dominant source of synovial fluid PPi has not been directly 
studied in man. However, it is likely that ePPi levels depend more on the PPi 
generating activity of PC1 than on the PPi transport function of ANKH. This is 
supported by the fact that ePPi levels in TNAP knockout mice is completely 
corrected in TNAP/PC1 double knockout mice but only partially corrected in 
TNAP/ANK double knockout mice (Hessle et al 2002; Harmey et al 2004). 
Moreover while PC1 is present in MVs, ANKH is not expressed there 
(Harmey et al 2004). 
Figure 29 Extracellular pyrophosphate metabolism and calcium 
pyrophosphate crystal formation 
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ePPi synthesis by NTPPPH.  
Of the three NTPPPH enzymes expressed by chondrocytes, PC1 (also 
termed ENPP1) apppears to be the only significant contributor to ePPi level 
(Lotz M 1995; Johnson et al 1999; Johnson 2001a; Johnson et al 2001b). 
Resting chondrocytes release ATP (adenosine tri-phosphate) which may be 
hydrolysed by PC1 producing AMP and PPi (Ryan et al 1992; Graff et al 
2000). Mechanically loaded chondrocytes secrete more ATP potentially 
increasing ePPi levels (Graff et al 2000) (Figure 30). Cartilage intermediate 
layer protein (CILP) was initially thought to have NTPPPH like activity (Hirose 
et al 2000). However, this was not confirmed in subsequent studies (Johnson 
et al 2003).  
 
 
Ankh in trans-cellular PPi transport  
The progressive ankylosis (ANK) gene in the mouse and its human 
homologue ANKH encodes a multipass transmembrane protein ANK 
 
 
chondrocyte 
Stress 
 
NTP 
 
PPi 
PC 1
Figure 30 Mechanical load increases extracellular 
pyrophosphate 
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(ANKH), which acts as a PPi transporter, allowing the elaboration of ePPi 
from intracellular sources (Ho et al 2000; Gurley et al 2006). ANKH has 
492 amino acids, weighs 54.3 kDa and is highly conserved in vertebrates 
(Netter et al 2004).  
The central role of ANKH and PC1 in CPPD is illustrated by a recent 
in-vitro study using human meniscal chondrocytes from knee OA and from 
non-OA knee chondrocytes (Sun et al 2010). In tissue cultures, meniscal 
chondrocytes from OA knees formed significantly more calcium crystals than 
non-OA chondrocytes, and this was associated with increased expression 
PC1, and ANKH genes (Sun et al 2010). Both hyaline articular cartilage and 
meniscal cells formed calcium crystals, but as would be expected, meniscal 
fibrocartilage chondrocytes formed more calcium crystals than the former 
(Sun et al 2010).  
PPi destruction  
ePPi is rapidly complexed to magnesium and then hydrolysed to 
orthophosphate (Pi) by TNAP - the main extracellular pyrophosphatase 
(Caswell et al 1983; Xu et al 1991; Xu et al 1994).  Intracellular PPi is 
hydrolysed by biosynthetic enzymes like glucose-6-phosphatase and other 
acid phosphatases (Terkeltaub 2001).  It is therefore expected that patients 
with hypophosphatasia have high systemic PPi levels and exhibit articular 
CPPD (Hamilton 1976).  
Source of elevated ePPi  
High ePPi concentration may result from increased PC-1, reduced TNAP, or 
increased ANKH activity (Figure 29). The situation with respect to TNAP and 
ANKH, however, is complex. For example, contrary to previous opinion, MV 
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bound TNAP generates PPi in the same way as ENPP-1 (Zhang 2005). To 
further complicate matters, a gain in activity of ANKH increases expression 
of sodium phosphate co-transporter (PiT-1) resulting in high intracellular Pi 
(Wang et al 2005) (Figure 31). This stimulates TNAP expression thus 
lowering ePPi (Wang et al 2005). Therefore, any increase in ePPi caused by 
increased PPi transport activity of ANKH may be reduced by this 
mechanism. However, these activities demonstrated in chick embryo growth 
plate cartilage have yet to be confirmed in adult mammalian chondrocytes 
(Wang et al 2005; Zhang 2005). 
Figure 31 Sodium phosphate co-transporter in pyrophosphate 
metabolism 
 
Growth factors also affect the ePPi levels (Table 12). Transforming growth 
IDFWRU ȕ 7*)ȕ DSSHDUV WR H[HUW D JUHDWHU HIIHFW LQ FDUWLODJH IURP ROGHU
animals, potentially explaining why the prevalence of CPPD increases with 
age (Rosenthal et al 1994; Rosen F 1997; Hirose et al 2000)7*)ȕalso has 
a greater effect on fibro- than hyaline cartilage, and on deep meniscal 
chondrocytes than on superficial ones, potentially explaining why 
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fibrocartilage is affected more often than hyaline cartilage, and in 
fibrocartilage, the deeper layers are more likely to be affected than superficial 
layers (Rosenthal et al 1993). 
Table 12 Regulation of pyrophosphate metabolism 
(Abhishek et al 2010) 
Substrate ĻĹ Regulatory Comments 
PC1 (ENPP1)    
 
Ĺ 7*)ȕ$JHLQJ
Thyroid hormone, 
Retinoic acid* 
,/ȕ,*)DQWDJRQL]HHIIHFWRI7*)ȕRQ3&$ 
 
Ļ ,/ȕ,*) CILP-1 antagonizes effect of IGF1 on PC1 
TNAP    
 
Ĺ ,/ȕ7K\URLGKRUPRQH 
 
Ļ 7*)ȕ$VFRUELFDFLG 
ANKH    
 
Ĺ 7*)ȕ Effect on ankh LVUHVSRQVLEOHIRURI7*)ȕ 
induced ePPi secretion  
 
Ļ IGF1 ,*)DQWDJRQL]HVHIIHFWRI7*)ȕ 
Transglutaminase     
 
Ĺ 7*)ȕ$JHLQJ 7UDQVJOXWDPLQDVHDOVRDFWLYDWHVODWHQW7*)ȕ 
 
Ļ IGF1  
CILP    
 
Ĺ 7*)ȕ$JHLQJ  
 
Ļ IGF1  
*Retinoic acid acts via TGFȕ$ May not inhibit effect of 7*)ȕLQFKRQGURF\WHVIURPSDWLHQWV
ZLWK&33'*ORVVDU\,/ȕLQWHUOHXNLQEHWD,*),QVXOLQOLNHJURZWKIDFWRU7*)ȕ
(transforming growth factor beta)  
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1.7.4 ANK(H) mutations in mice and man 
The gene responsible for progressive ankylosis in mice, described in the 
1980s (Sweet 1981; Hakim 1984) was identified on the mouse chromosome 
15 (Ho et al 2000). In mice, the autosomal recessive (ank/ank) progressive 
ankylosis phenotype shows spontaneous bony ankylosis of peripheral, and 
axial joints, destructive arthropathy, and osteophytosis due to hydroxyapatite 
deposition (Hakim 1984; Ho et al 2000). This results from a nonsense 
mutation (G to T) in an integral multipass portion of ANK (Ho et al 2000). 
Consequently, the ePPi concentration is low (Figure 32), leading to extensive 
calcification by hydroxyapatite crystals (Sweet 1981; Hakim 1984; Ho et al 
2000).  
ANKH mutations have different effects in men. Unlike mice, mutations 
in ANKH lead to CPPD and are inherited in an autosomal dominant manner 
(Gaucher et al 1977; Doherty et al 1991; Hughes 1995; Andrew et al 1999; 
Williams et al 2003). More importantly, these mutations are believed to 
confer a gain in PPi transport function leading to increased ePPi levels 
(Figure 32) (Pendleton et al 2002). It is hypothesized that chronically 
elevated levels of ePPi result in CPPD (Pendleton et al 2002). However, not 
all ANKH mutations have been shown to result in high ePPi in vitro and it is 
possible that there may be other yet undefined mechanisms (Pendleton et al 
2002; Zhang et al 2005).  
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Figure 32 ANK(H) in mice and man  
 
1.7.5 Genetics of chondrocalcinosis 
Mutations in ANKH cause familial CPPD (Gaucher et al 1977; Doherty et al 
1991; Hughes 1995; Andrew et al 1999; Williams et al 2003) (Table 14). 
Such familial CPPD may manifest as CC, acute CPP crystal arthritis, or as 
chronic CPPD arthropathy (Gaucher et al 1977; Doherty et al 1991; Andrew 
et al 1999; Williams et al 2003). In one UK kindred characterized by 
polyarticular CC without structural arthropathy, a mutation in ANKH also 
associated with recurrent infantile seizures from the age of 6 months to 6 
years without subsequent mental impairment (Doherty et al 1991). However, 
there are no reports of seizures in other families with mutations in ANKH 
(Gaucher et al 1977; Andrew et al 1999; Williams et al 2003).  
Familial CC has been reported due to mutations in other genes as 
well. A large US pedigree with early onset OA and CPPD with genetic defect 
localized to chromosome 8q (CCAL1) was reported (Baldwin et al 1995), but 
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the responsible gene has not been identified to date. In this family, CPPD 
appears to be secondary to severe non-dysplastic OA.  Similarly, mutation in 
the procollagen type 2 gene (COL2A) leads to severe early OA, 
spondyloepiphysial dysplasia, and secondary CPPD (Netter et al 2004). 
In a study of 95 British Caucasians with apparently sporadic CC, one 
instance of familial CC and premature OA was identified (Pendleton et al 
2002). Affected members of this family had the E490del mutation in ANKH 
(Pendleton et al 2002). In another UK based case-control study, a -4bp G to 
$VLQJOHQXFOHRWLGHSRO\PRUSKLVP613LQWKH¶-UTR of ANKH associated 
with CPPD (OR (95%CI) for development of CPPD in homozygous state = 
6.00 (2.2-16.5), p=0.0006) (Zhang et al 2005). The mechanisms by which 
these mutations and the SNP may induce CPPD are described in Table 13. 
To date, other studies examining the association between SNP in genes of 
enzymes involved in PPi metabolism have shown that genetic 
polymorphisms in PC1 and TNAP do not associate with sporadic CC (Zhang 
et al 2007).  
 The effects of ANKH mutations on PPi levels are conflicting. This may 
be because the gain-of-function mutations in ANKH are subjected to a 
feedback transcriptional down regulation. Moreover, the expression profiles 
of genes that regulate Pi and PPi are themselves changed by the Pi and PPi 
levels (Wang et al 2005). Similarly, over-expression of ANKH stimulates PiT-
1 leading to high intracellular Pi which in turn stimulates TNAP expression, 
resulting in low intracellular and extracellular PPi (Zaka 2006; Wang et al 
2009). Finally, most in vitro studies measure bulk PPi level days after 
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transfection with mutant ANKH. During this time other reactions may affect 
PPi levels, making it difficult to compare results across experiments (Zhang 
et al 2005; Gurley et al 2006; Zaka 2006).      
Table 13 Genetic variation in ANKH associated with calcium 
pyrophosphate deposition  
Location cDNA 
position1 
Nucleotide 
variation 
Amino acid change 
(position) 
 
Type of 
mutation 
Role in 
sporadic CPPD 
¶875 -11bp C to T +4 amino acid            
(1-4) 
Base 
substitution 
No 
¶875 -4bp G to A NA2 Transition Yes 
Exon 1 +13bp C to A Pro to Thr (5) Missense Not known 
Exon 1 +14bp C to T Pro to Leu (5) Missense No  
Exon 2 +143bp T to C Meth to Thr (48) Missense No  
Exon 12 +490bp GAG del Glu deletion (490)  No 
1c DNA posn.1: ATG initiation codon, 2 not applicable 
(Doherty et al 1991; Hughes et al 1995; Andrew et al 1999; Pendleton et al 
2002; Williams et al 2003; Zhang et al 2005) 
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Table 14 Mechanisms underlying calcium pyrophosphate deposition 
due to genetic variations in ANKH 
cDNA  
nucleotide change 
possible mechanisms underlying CPPD  
Ankh gene 
expression 
e or i PPi level in rare allele 
vs. wild type 
effects on other 
proteins 
¶875-4bp G to A > wild type ePPi > wild type  no effect on PC1, 
TNAP 
¶875-11bp C to T1 not known   iPP < wild type not reported 
Exon 1+13bp C to A = wild type  ePPi =, iPPi  > wild type2 no effect on PC1, 
TNAP  
Exon 1+14bp C to T >/= wild type  ePPi >/ = wild type no effect or 
increase PC1, no 
effect TNAP  
Exon 2+143bp T to C = wild type  
 
ePPi =, i PPi  =/>4 wild type  No effect or high 
PC1, TNAP. 
Mutant ankh does 
not interact with 
PiT-1. 
Exon 12+490bpGAG 
del 
> wild type ePPi, i PPi  = wild type no effect on PC1, 
TNAP no effect or 
low 
 
1generates an alternative initiation codon putatively adding 4 amino acids to the N-terminus. 
This may lead to a larger pore size, increasing PPi leakiness. 2 skin fibroblasts 3 skin 
fibroblasts and lymphoblast 
(Lust et al 1981; Ryan et al 1986; Pendleton et al 2002; Zhang et al 2005; 
Gurley et al 2006; Zaka et al 2006; Wang et al 2008; Wang et al 2009)  
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1.7.6 Cartilage matrix changes promoting chondrocalcinosis  
Changes in the cartilage matrix may encourage CPPD. CPP crystals form in 
areas of abnormal pericellular matrix, and are most commonly observed in 
areas showing reduced total collagen content, elevated type 1 collagen, 
damaged type 2 collagen, increased calcium binding matricellular proteins, 
few large proteoglycans, numerous small proteoglycans, and abundant 
phospholipids (Ishikawa 1985; Ishikawa et al 1989; Kalya et al 2005; Jubeck 
et al 2008). Transglutaminase enzymes (type 2 and factor XIIIA) induce 
cross links in cartilage matrix and activate osteopontin induced CPP crystal 
nucleation (Rosenthal et al 2000; Rosenthal et al 2001; Heinkel et al 2004; 
Rosenthal et al 2007). Interestingly osteopontin itself stimulates 
transglutaminase activity providing a positive feedback loop (Rosenthal et al 
2007).  
Histologically, CPP crystals also co-localise with hypertrophic 
chondrocytes which associate with adjacent matrix changes and with high 
ePPi levels (Masuda et al 1991; Rosenthal et al 1999). Furthermore, both the 
hypertrophic chondrocyte phenotype and the cartilage matrix changes that 
encourage CPP crystal formation are common features of OA, which may 
explain the association between CPPD and OA.  
115 
 
1.8 Hypothesis and rationale for the study 
Although there is a strong association between OA, ageing and CC; it is not 
well established as why only some patients with OA, and some elderly 
people develop CC. The risk factors for CC remain poorly defined, and much 
of the information is derived from clinical observation, case series, and 
hospital based case-control studies. For example, mechanical loading of 
chondrocytes leads to high synovial fluid PPi. It is unknown if other factors 
leading to increased mechanical loading of the joint such as body weight, 
body shape, knee mal-alignment, and occupational joint use associate with 
CC. Early small studies reported an association between knee malalignment 
and knee CC (Ellman et al 1975; Hernborg et al 1977). However, this has not 
been examined in a large study. Similarly, the association between joint 
injury, joint surgery e.g. meniscectomy, and CC have not been examined in a 
systematic manner. Also the association between diuretic use and CC, 
hypothesized to be mediated by diuretic-induced hypomagnesemia, has not 
been replicated. It is hypothesized that as PPi is complexed to magnesium 
before being hydrolysed to Pi by TNAP, low magnesium levels will lead to 
higher PPi and predispose to CPP crystal formation.  
Although PPi metabolism is reasonably well understood, the precise 
change leading to excess ePPi in those with CPPD is unknown. The studies 
of association between SNPs in TNAP, PC1 and high ferritin (HFE) gene and 
sporadic CC, are limited by the fact that the control group has not been 
screened for absence of CC, and the analysis has not been adjusted for the 
presence of OA.  
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 As excess ePPi favours CPP crystal formation, and inhibits BCP 
crystal formation and growth; it is likely that patients with CC will have a low 
bone mineral density (BMD).  However, CC also associates with OA which 
itself associates with high BMD. The association between CC and BMD is 
yet to be examined. The radiographic distribution of CC at the knees, wrists, 
MCPJs, and hips has only been studied in hospital based case series and in 
a few small case-control studies. Similarly, the association between hip OA, 
MCPJ OA or wrist OA and CC at these sites has been examined in small 
hospital based studies only. There are numerous small and often conflicting 
reports of a distinct radiographic phenotype of structural changes in joints 
with OA + CPPD, compared to joints with OA alone. A large systematic 
survey examining whether CC at a joint modifies the radiographic 
appearance of OA at that joint is required to clariy the matter.  
  In this study, we will examine the radiographic distribution of CC at 
knees, hips, symphysis pubis, wrists, and of MCPJ calcification. We 
hypothesize that the following will increase the risk of CC: 
[1] increased joint load and adverse mechanical factors due to high BMI, 
large body shape, knee malalignment, prior joint injury or surgery, and 
occupational joint use 
[2] diuretic intake 
[3] SNPs in genes encoding enzymes involved in PPi metabolism.  
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We also hypothesize that individuals with CC will have a low BMD; 
and that joints with OA + CC will have a different radiographic phenotype of 
structural arthropathy compared to joints with OA alone.    
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 1.9 Introduction to the GOAL study 
Genetics of Osteoarthritis and Lifestyle (GOAL) is a case-control study of 45-
80 year old Caucasians that recruited 1042 knee OA cases, 1007 hip OA 
cases, and 1121 controls. The GOAL study was approved by the Nottingham 
City Hospital Local Research Ethics Committee (reference EC02/06) in 
February 2002, and was funded primarily by AstraZeneca, UK as a 
collaborative project with the University of Nottingham, UK.  
Cases with hip OA were Nottingham residents, awaiting or having 
undergone total hip replacement (THR) for primary hip OA. They were 
recruited from the orthopaedic waiting lists of the City Hospital Nottingham 
(CHN) or Queens Medical Centre (QMC). Cases with knee OA were 
recruited in the same manner except for a small number of severe 
symptomatic knee OA cases who were recruited from a specialist knee OA 
rheumatology clinic. Where possible, knee and/or pelvis radiographs of 
potential cases were examined prior to recruitment to ensure that the total 
joint replacement was performed for OA. The controls were all Nottingham 
residents recruited from the intravenous urogram (IVU) lists at CHN or QMC. 
This identified patients who have had an x-ray of the pelvis. The pelvis x-ray 
was used to ascertain that they did not have hip OA.   
Participants were classified as they were recruited. For cases, the 
ascertainment was severe symptomatic large joint OA sufficient to warrant 
referral to hospital for consideration of surgery or having already undergone 
total joint replacement (TJR) for severe symptomatic OA at the hip or knee in 
the last 5 years. Controls were ascertained as individuals with no symptoms 
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or clinical signs of OA, and no history of treatment for OA. Cases and 
controls were matched for age and gender.  
Detailed information about the demographics, lifestyle, and social 
history was collected by a metrologist during a home visit. The metrologist 
examined the participant to assess their OA status. A comprehensive food 
frequency questionnaire (FFQ) about diet in their 4th decade was given to the 
participant to complete and bring to the hospital visit. At the hospital visit, 
participants underwent a clinical questionnaire; had a joint examination, 
mobility assessment, and anthropometric measurements; gave blood and 
urine samples; and had x-rays of the hips, knees and hands (if not 
undertaken within the past 12 months). Genomic DNA was isolated from 
whole blood and extracted using Gentra PureGene extraction methods.  
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1.10 Aims and Objectives 
The aims of this study were to:  
[1] describe the distribution of CC, 
[2] explore the known and putative risk factors for CC, and 
[3] determine whether CC at a joint associates with a specific radiographic 
OA phenotype.  
The specific objectives were to:     
[1] describe the distribution of CC at the knees, pelvis and hands. 
[2] investigate the putative constitutional and environmental risk factors for 
the development of CC including: age, gender, OA, BMI, self-reported body 
shape,  frontal plane knee malalignment (current and previous), BMD, soft-
tissue calcification, diuretic use, occupational joint use, and knee injury, or 
surgery.  
[3] study the SNPs in candidate genes in cases with sporadic CC and 
controls. 
[4] compare the radiographic phenotype of cases with CC plus OA at a joint 
with that of controls with OA alone at the same joint, and in the presence of 
local effects, to examine for the presence of distant effects by comparing 
radiographic phenotype of cases with CC at distant joints and OA at the 
index joint, to that of controls without CC at distant joints and with OA at the 
index joint. 
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Chapter 2 Methods 
2.1 The GOAL study 
The GOAL study was established primarily for case-control studies to 
examine gene-environment interaction, and specific genetic risk factors 
associated with hip or knee OA.  
The 3170 participants in the GOAL study were recruited into 3 groups: 
a) Knee OA (case): 1042 participants (536 male) with symptomatic and 
radiographic knee OA, sufficiently severe clinically to warrant referral to 
hospital and/or consideration for joint replacement 
b) Hip OA (case): 1007 participants (499 male) with symptomatic and 
radiographic hip OA, sufficiently severe clinically to warrant referral to 
hospital for consideration of joint replacement 
c) Control: 1121 participants (600 male) without symptoms, signs or 
radiographic evidence of knee or hip OA. 
2.1.1 Case recruitment 
Patient identification: Participants who had undergone, or were on the 
waiting list for total joint replacement (TJR) were considered for recruitment 
(Figure 33). Orthopaedic waiting lists obtained from the Information Bureaux 
at the CHN and QMC were used to recruit participants.  Patients referred 
with clinically severe symptomatic knee OA to the Nottingham Knee OA 
Clinic were also considered for recruitment.  
Pre-contact patient checks: The pre-operative radiographs (for TJR) or 
current radiographs (if on waiting list for surgery) were screened by the 
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Senior Research Metrologist to check for (1) presence of radiographic OA, 
and (2) absence of other joint or bone disease as the indication for TJR (eg 
rheumatoid arthritis, osteonecrosis, fracture) which would exclude the patient 
from GOAL. Prior to contact with participants, their current status and 
address were checked on the Nottingham Hospitals Patient Administration 
6\VWHP 3$6  1R FKHFNV ZHUH PDGH ZLWK WKH SDUWLFLSDQWV¶ JHQHUDO
practitioner (GP).   
Method of contact: A letter of invitation signed by the operating surgeon, a 
participant information sheet, and a GOAL leaflet were sent to each person. 
If they responded positively they were then contacted by telephone within the 
following two weeks to discuss the study in more detail, to answer any 
questions, and to screen for any exclusion criteria (See section 2.1.3).  
2.1.2 Recruitment of controls  
Identification of controls: All controls were recruited from IVU lists from CHN 
and QMC (Figure 33). These lists were obtained from the hospital 
Information Bureaux. In the first part of the study, no age matching was 
undertaken in order to facilitate recruitment of controls.  However, in the last 
study year age matching was undertaken to ensure an appropriate age mix 
in the control group to both the knee and hip OA groups. Age matching was 
by date of birth plus or minus 2 years. 
Pre-contact checks: Prior to contact with participants their current status and 
address were checked on the Nottingham University Hospitals Patient 
$GPLQLVWUDWLRQ6\VWHP 3$6 1RFKHFNVZHUHPDGHZLWK WKHSDUWLFLSDQWV¶
GP.   
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Method of contact: For confidentiality reasons, the first letter to the potential 
control was sent with the address of the Radiology Department where their 
IVU was undertaken and signed by the Radiology Directorate representative. 
This first letter asked (1) for their permission to view their x-rays to check for 
presence of OA or other joint disease, and (2) whether they might wish to 
participate in the GOAL study should their pelvis x-ray show no hip OA.  If 
after two weeks no reply was received, a single postal reminder was sent. 
If the participant answered in the affirmative, and gave consent for 
their radiograph to be examined, their IVU film was obtained and screened 
for hip OA status by the Senior Research Metrologist.  If the hip joints 
showed evidence of OA, inflammatory arthritis or partial or total hip joint 
replacement, they were excluded from the study.  
If the control had a normal pelvic radiograph, they were sent a further 
letter of invitation to participate in GOAL study with a participant information 
sheet and GOAL leaflet.  This letter was followed up by a telephone call to 
inform the participant about the study in more detail, to answer any 
questions, and to screen for any exclusion (see below).   
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Figure 33 Recruitment of participants in the GOAL study  
  
Completed 1121    
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2.1.3 Exclusion criteria 
The following were exclusion criteria for this study: known diagnosis of 
DQN\ORVLQJ VSRQG\OLWLV 3DJHW¶V GLVHDVH RI ERQH 3HUWKH¶V GLVHDVH VOLSSHG
femoral epiphysis, trauma directly before a joint replacement, hip dysplasia, 
avascular necrosis of femoral head or distal femoral condyle, congenital 
deformities and polio. Any patient suffering with long-term serious illnesses, 
such as carcinoma, myeloma, severe dementia, severe respiratory/renal 
problems (as confirmed on their x-ray report) or with inability to give fully 
informed consent were excluded. 
2.1.4 Data collection  
Patients with knee or hip OA were seen twice; at home for their initial 
appointment, and at CHN to complete the assessment. At the home visit, the 
metrologist performed an initial assessment using a standardised protocol to 
FKHFNWKHSDUWLFLSDQW¶V2$VWDWXV 
Home visit: An extensive questionnaire was completed by the metrologist at 
the home appointment. This included information about general educational 
background, ethnic origin, siblings, occupational history, activity history, 
footwear, diet, dietary supplements, medical history and male and female 
hormonal history. At the end of the home visit, an extensive diet 
questionnaire was left with the subject for them to complete and return when 
they attended for their hospital appointment.  The questionnaire asked about 
WKHGLHWGXULQJWKHLU¶VDQG¶V 
Hospital visit: At the hospital, information about knee and hip pain; significant 
injury to knees, hips and other joints; surgery to knees, hips and other joints; 
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pain in other joints; fractures; recent pain and stiffness in the knees, hips or 
hands (within the last year) was collected. Participants also filled in the 
AUSCAN and WOMAC questionnaires (Bellamy N et al 1988).  
7KH SDWLHQW¶V KHLJKW ZHLJKW ZDLVW circumference, hip circumference 
and arm span were measured in centimetres. The metrologist performed a 
targeted joint examination of the knees, hips, hands and feet. At this point, a 
blood sample was taken, a urine sample was given (second or third void, 
morning specimen) and the patient underwent a calcaneal dual energy x-ray 
absorptiometry (DEXA) scan. Participants had new x-rays of their hands, 
knees and pelvis, unless these had been performed within the last 2 years 
on joints that had not been replaced. All pre-surgical films of the knees 
and/or pelvis were sought prior to arranging first contact with the participant. 
For pre-surgical knee x-rays, lateral patello-femoral and non-weight-bearing 
tibio-femoral films were acceptable. For patients having new radiographs, a 
standardised protocol was used.  The Rosin template (standing semi-flexed) 
was used for tibio-femoral compartments and a skyline view was taken of the 
patello-femoral compartments. Supine pelvis and AP hand views were taken.  
Controls underwent an identical questionnaire, examination, and 
investigational procedure to provide equivalent data as for cases for the 
GOAL database.    
Follow up questionnaire: In January 2008, a follow up questionnaire was 
mailed to all live GOAL participants who were still resident in the UK 
(n=3022). Of these, 89 declined participation, 43 were lost to follow-up, and 
32 died during or after follow-up questionnaire. Therefore, of the 3022 
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questionnaires sent out, 2172 completed response were returned, yielding a 
response rate of 71.9%. The additional questionnaire enquired about the 
relative length of index and ring fingers from both hands (2D:4D ratio), hallux 
valgus (using a line-drawing instrument), physical activity (occupational, 
recreational and domestic) including climbing stairs, body shape, knee and 
foot alignment (using a line-drawing instrument): currently and in their 20s, 
history of cardiovascular diseases and osteoporosis, family history of OA, 
and footwear use (using a line drawing instrument). This questionnaire also 
included a food group table, to establish the test re-test intra-rater reliability 
for the FFQ. 
Storage of recorded data, samples and quality control: All information was 
entered onto a structured query language server database and linked to the 
serially numbered DNA and other samples for each participant. The master 
database is held in Academic Rheumatology, University of Nottingham, UK. 
Biological samples are stored as blood, plasma, serum and urine.  
The questionnaires were checked manually by designated personnel. 
10% of all data entered into the database was checked against the 
questionnaire.  The minimum accuracy was 98% for each section of the 
questionnaire.  The accuracy under this threshold required full data check 
and re-entry for the section. To ensure all metrologists were gathering high 
quality data, they were assessed once every 2-3 months. Feedback was 
given by the assessor shortly after the interview, in order to aid improvement 
for future interviews. 
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 2.1.5 Available radiographic measurements  
As mentioned before, all participants in the GOAL study underwent knee, 
pelvis and hand radiographs. These radiographs were scored by a single 
trained Senior Research Metrologist for the presence or absence of CC at 
the knees, hips, symphysis pubis, wrists and for synovial calcification at the 
MCPJs. As there is no radiographic atlas of CC, the senior research 
metrologist was trained and guided by Professor Doherty in the interpretation 
of CC, and MCPJ calcification. CC was regarded as present if there was a:  
a) linear calcification in fibro- or hyaline articular cartilage, or 
b) spotty cartilage calcification, arranged in a linear manner, 
predominantly seen in the fibrocartilage, or  
c) µFORXG\¶V\QRYLDOFDOFLILFDWLRQHVSHFLDOO\DWWKH0&3-V 
All knee radiographs with CC were scored for its compartmental (lateral, or 
medial TFJ compartment), and cartilaginous (hyaline- vs. fibro cartilage) 
location. Knee, hand, and pelvis radiographs of twenty GOAL participants for 
each of the three joint regions were randomly selected (approximately 25% - 
35% with CC) and re-scored for CC by the Senior Research Metrologist, and 
another independent observer (AA) for determining the intra-rater and inter-
rater agreement. The observers were blinded to each other, and to the 
previous CC scores. The overall intra- and inter rater agreement (k statistic 
(95%CI) for CC at any site was 0.96 (0.93-0.98), and 0.96 (0.93-0.98) 
respectively. The intra-rater agreement (k statistic (95%CI) for CC at the 
knee, pelvis, and hand was 1, 1, and 0.90 (0.75-0.96) respectively. The inter-
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rater agreement (k statistic (95%CI) for CC at the knee, pelvis, and hand was 
1, 0.94 (0.84-0.98), and 0.94 (0.84-0.98) respectively.   
There are potential methodological problems with using plain 
radiographs for detecting CC at different sites. This is as the sensitivity of 
plain radiographs for the detection of CC may vary from site to site. This may 
be a particular problem in the case of hip CC. Hip CC may be more difficult 
to detect than knee CC, especially in the presence of OA. However, other 
imaging techniques like ultrasound have not been validated for CC at joints 
other than the knee, and it would be difficult to do an ultrasound study of CC 
in such a large number of people at so many joints.     
These radiographs were also scored for structural radiographic 
changes of OA by the same single observer. At the knee, osteophytes at 
each of the eight sites (medial and lateral tibial, femoral, patellar, and 
trochlear) were graded according to their size (grade 0 - 5) (Nagaosa et al 
2002). Joint space narrowing was graded for each (medial and lateral) TFJ  
and PFJ compartment using an ordinal line diagram atlas, with negative 
scores indicating joint space widening (grade -1 to 5) (Wilkinson et al 2005). 
Knee radiographs were also scored for the presence or absence of attrition, 
and subluxation at the TFJs, and PFJs.  
Hip radiographs were scored for osteophytosis, sclerosis, cysts, and 
the minimum joint space width was measured in millimetres correct to two 
decimal places. Osteophytes at the femoral neck, femoral head, and 
acetabulum were scored on a 0-3 ordinal scale (Altman et al 1995). Sclerosis 
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and cysts were scored as present or absent at the femoral head and at the 
acetabulum.      
The radio-carpal, mid-carpal, common carpo-metacarpal, first carpo-
metacarpal, scapho-trapezoid, individual MCP, and IP joints were scored for 
the severity of osteophytosis (0-3), joint space narrowing (0-3), and for 
presence of cysts (0,1), sclerosis (0,1) and erosions (0,1) using the OARSI 
radiographic atlas (Altman et al 1995).  
TFJs, PFJs, hips, 1st CMCJs, MCPJs, and IPJs were allocated a 0-4 
Kellgren & Lawrence (K&L) score for global OA severity (Altman et al 1995). 
Knee and pelvis radiographs were scored for the presence of peri-articular 
soft-tissue calcifications, and pelvis radiographs were scored for the 
presence of vascular calcifications. Intra-rater reliability was calculated for 
the scoring of structural radiographic changes of OA as part of the GOAL 
study, and is enclosed in appendix iv.      
2.1.6 New radiographic measurements  
Frontal plane knee alignment was measured on all knee radiographs. The 
mechanical axis is the gold standard measure of knee alignment and is the 
angle formed by a line from the centre of the head of the femur to the centre 
of the tibial spines and from the centre of the tibial spines to the midpoint of 
the talus at the ankle joint (Moreland et al 1987). This requires a weight-
bearing AP radiograph of both lower extremities from the pelvis to the ankle 
(Moreland et al 1987; Sharma et al 2001).These full-limb radiographs are 
expensive, entail radiation exposure to the pelvis, require skilled 
radiographers and special equipment (Kraus et al 2005). The radiation from 
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standard knee x ray is 3 millirems while that from standard and digital full 
length x ray is 51 and 15 millirems respectively (McDaniel et al 2010). This 
makes the full limb radiograph unsuitable for use in large epidemiologic 
study. 
 The anatomic axis measured on standard posterior anterior (PA) and 
AP knee radiographs on a 14x17 inch cassette is a valid surrogate of the 
mechanical axis (Kraus et al 2005). Techniques for the measurement of 
anatomic axis are based on two broad principles:  
(1) Join a line from the midpoint of the femoral shaft 10 cm from the knee 
joint to the centre of the tibial spine with a line from the midpoint of the 
tibial shaft 10 cm from the knee joint to the centre of the tibial spines. 
There is some variation between studies as to how the centre of the tibial 
spines is defined (McDaniel et al ; Kraus et al 2005; Hinman et al 2006; 
Colebatch et al 2009; Wong et al 2009). Some studies recommend using 
a goniometer to identify the midpoint of the femoral and tibial shafts 18 
cm away from the centre of the tibial spines (Issa et al 2007). 
(2) Join the femoral and tibial anatomic axis. The femoral anatomic axis 
is represented by a line joining two points in the mid-femoral shaft, 10 cm 
and at least 15 cm from the femoral condyle. Similarly, the tibial 
anatomic axis is represented by the line joining two points in the mid- 
tibial shaft, 10cm and at least 15 cm from the tibial plateau. (Prakash et 
al 2001; Takahashi et al 2004)  
The former approach is most extensively studied, and has good inter- 
and intra-observer reliability with an intra-class coefficient ICC >0.92 (Kraus 
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et al 2005; McDaniel et al 2010; Takahashi et al 2004; Hinman et al 2006; 
Issa et al 2007; Felson et al 2009; Wong et al 2009).  
The anatomic axis has a good to excellent correlation with the 
mechanical axis (r=0.54-0.88). In a recent study, the anatomic axis 
measured using the midpoint of the tibial spine tips, projected downwards on 
to the tibial plateau as the centre of the angle had the best correlation with 
the hip-knee angle (r=0.65)  (McDaniel et al 2010).  
Knee alignment assessed by the anatomic axis is offset from the 
mechanical axis angle in the valgus direction. The offset is mainly due to the 
femoral neck which is not included in the 14 x 17 inch knee radiograph. It 
may also be explained by femoral and tibial bowing in individuals with OA, 
which again is not measured on a standard 14x17 inch knee radiograph 
(Chang et al 2010). The offset on PA radiographs is 3.27o for women and 
5.87o for men, and on AP radiographs is 3.10o for women and 7.40o for men 
(Kraus et al 2005). Recent studies suggest that the degree of offset may vary 
according to the severity and direction of knee mal-alignment (Sheehy et al 
2011). However, unfortunately these studies do not provide offset values that 
can be applied to short axis films of varying degrees of knee OA severity.   
The anatomic axis measured on knee radiographs is sensitive and 
specific for the diagnosis of varus or valgus knee malalignment. Using the 
mechanical axis measured on full limb radiographs as the gold standard, the 
sensitivity and specificity for varus and valgus knee mal-alignment (defined 
as: any deviation from 0o (the neutral)) measured on knee radiographs was 
0.84, 0.84; and 0.98, 0.73 respectively. When a deviation of >2o from neutral 
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was used for defining varus or valgus knee mal-alignment the sensitivity and 
specificity were 0.82, 0.90; and 0.91, 0.84 respectively (Issa et al 2007).  
Varus or valgus knee mal-alignment measured by the method of 
Krause et al. has been shown to have predictive validity for progression of 
knee OA. The OR (95%CI) for progression of medial compartment knee OA 
in varus knee mal-alignment was 4.82 (1.93-12.00) using full limb 
radiographs and 4.25 (2.08-8.72) using short knee radiographs (Felson et al 
2009).  
The mechanical axis can be calculated from the anatomic axis, either 
by subtracting the offset, or by using one of the several proposed formulae. 
Different formulae have been proposed for AP and PA knee radiographs. 
AP view:   
mechanical axis = (anatomic axis)*0.67 + 55.86, r=0.65 (Kraus et al 2005) 
mechanical axis = (anatomic axis)*0.915 + 13.895, r=0.88 (Hinman et al 
2006) 
PA view:  
mechanical axis = (anatomic axis)*0.69 + 53.69, r=0.75 (Kraus et al 2005) 
However, the anatomic axis may only provide an imperfect estimate of 
the mechanical axis. For example, in another study the correlation between 
categorical knee mal-alignment assessed on knee radiographs and that on 
full length lower limb radiographs was only moderate to good (r =0.43-0.74) 
(Colebatch et al 2009; Felson et al 2009). Other investigators have reported 
only a moderate correlation (r=0.34) between the anatomic and mechanical 
axis at the knee (van Raaij et al 2009).  
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In summary, we have selected the method developed by Krause et al. 
to measure knee mal-alignment in our study as it has been shown to have 
predictive validity for progression of knee OA (Felson et al 2009), and has 
the best correlation with the hip-knee angle (r=0.65) in a direct comparison of 
five methods for measurement of knee mal-alignment using short axis knee 
radiographs (McDaniel et al 2010). 
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2.2 Epidemiological analysis 
2.2.1 Study design, and case definition  
This is a case-control study embedded in the GOAL study (n=3170). For the 
current analysis, the original groups of GOAL participants recruited according 
to their knee or hip OA status were merged together. Participants were then 
reclassified according to the presence or absence of CC at any joint. Cases 
with CC were compared with controls without CC. 
Case definition for analysis of risk factors of CC: 
All GOAL participants were included in the analysis of risk factors of CC. 
Cases were participants with CC at any knee, hip, symphysis pubis, wrist, or 
with calcification at any MCPJ. Controls were participants without CC at all 
the above mentioned sites, and without MCPJ calcification. For examining 
the constitutional, genetic, and environmental risk factors of CC, cases with 
CC at any site were compared with controls without CC at all sites (person 
based analysis).  
Case definition for analysis of radiographic phenotypes associated with CC 
plus OA:  
Only participants with radiographic OA at the index joint were included in this 
analysis. Participants were considered to have OA at the index joint if there 
was definite joint space narrowing in that joint LH.	/JUDGHDWthe knee, 
MCPJs or thumb-EDVHRUDW WKHKLSGHILQLWH-61 VFRUHRIRQD-3 
scale) at the radio-carpal, mid-carpal, common carpo-metacarpal joint or 
STJs (as above). In order to examine if CC plus OA associates with a 
distinctive radiographic phenotype at the index joint compared to OA alone, 
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cases were participants with CC plus OA at the index joint and controls were 
participants with OA alone at the same joint. Any association with a specific 
radiographic phenotype would suggest a local effect of CC on that particular 
OA phenotype at that joint. Right and left sides were compared separately 
(joint based analysis). If a local effect was present further analyses were 
carried out to examine if CC at distant joints associated with that particular 
structural radiographic change at the index joint. For this analysis, 
participants with CC at the index joint were excluded to reduce any 
confounding by local effects.   
2.2.2 Scoring of exposure variables, and epidemiological analysis  
2.2.2.1 Age, gender 
$JHDWKRVSLWDOYLVLW \HDUVZDVFRQVLGHUHGWKHSDUWLFLSDQW¶VDJH7KLVZDV
converted into tertiles for all analyses. Risks were computed for age in 
tertiles with the 1st tertile being referent. Information about gender was 
collected at the home visit. For the purpose of this study, female gender was 
1, and male 0. Risks were computed for female gender with male gender 
being referent.  
2.2.2.2 Osteoarthritis  
For the analysis of association between OA as a risk factor for CC 
SDUWLFLSDQWV ZHUH FRQVLGHUHG WR KDYH 2$ LI WKH\ KDG D .	/ VFRUH RI DW
HLWKHU KLS RU D .	/ VFRUH RI  DW HLWKHU 7)-V RU 3)-V 1RGDO 2$ ZDV
present if there was at least one node (either Heberden, or Bouchard) on two 
rays of each hand. Similarly nodal GOA was present if there was nodal OA 
and OA at either hip or TFJs or PFJs as defined above. Risks were 
computed for OA, nodal OA, and nodal GOA.  
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Risks were computed for the association between OA and CC at the 
index joint and for the association between OA at the index joint and CC at 
distant joints. Risks were also computed for the association between OA on 
one side and CC on the opposite side for each joint area.   
 Risks were computed for number of knee compartments with OA 
changes and CC at the same knee. For this, a knee was regarded to have 
three compartments: the medial and lateral TFJ and the PFJ. A knee 
compartment was considered to have OA if there was definite joint space 
narrowing in WKDWFRPSDUWPHQWLHDMRLQWVSDFHQDUURZLQJVFRUHRIXVLQJ
the ordinal Nottingham line diagram atlas for knee joint space width 
measurements (Wilkinson et al 2005). The number of compartments with 
knee OA was calculated for each side and risks of knee CC for increasing 
number of knee compartments with OA (0-3) were calculated, with no knee 
compartment with OA being the reference category.     
2.2.2.3 Body Mass Index 
3DUWLFLSDQWV¶ ZHLJKW NLORJUDP DQG KHLJKW PHWHU ZHUH PHDVXUHG WR WKH
second decimal point at the hospital visit. This was used to calculate their 
current body mass index (BMI) as kg/m2. Participants self-reported their 
weight in each decade of life starting from their third decade (20s). This and 
the current height were used to calculate the BMI in each decade of their life. 
Current BMI and BMI in their 20s, 30s etc were used as indicators of obesity 
at the relevant age (i.e prior to, and at the time of development of CC or OA). 
BMI was converted to tertiles, and used for all analyses. Risks were 
computed for BMI in tertiles, with the 1st tertile being the reference category. 
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2.2.2.4 Body shape 
Men and women self-reported their body shape in each decade of their life 
beginning from the 20s, as well as their current shape. A separate ordinal 
line diagram instrument was used for each gender, with nine drawings 
labelled from 1-9 (Figure 34). This line diagram instrument requires 
participants to select one of the nine drawings which best represents their 
body shape in their 20s, as well as current body shape. For this study, 
participants selecting body shape 1-4 were regarded as referent, and 
SDUWLFLSDQWVVHOHFWLQJERG\VKDSHZHUH UHJDUGHG as exposed to the risk 
IDFWRUDWWKDWDJH5LVNVZHUHFRPSXWHGIRUWKHERG\VKDSH 
 
Figure 34 Line diagram instrument for self-reported body shape 
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2.2.2.5 Self-reported knee mal-alignment (current and previous) 
Information about self-reported current knee malalignment and knee 
malalignment in their 20s was obtained from the responses to the follow-up 
questionnaire mailed to the GOAL participants in January 2008 (Figure 35). 
Self-reported knee alignment was assessed using a validated line diagram 
instrument (Ingham et al 2010). This line diagram instrument has good 
UHSURGXFLELOLW\ ț  DQG JRRG LQWHU-REVHUYHU DJUHHPHQW ț 
(Ingham et al 2010).  
 
Figure 35 Line diagram instrument for self-reported knee alignment 
For the purpose of this analysis, participants who were very bow 
legged (A) or bow legged (B) were considered to have varus knee 
malalignment, and participants who had very knock-knees (E) or knock-
knees (D) were considered to have valgus knee malalignment. Risks were 
computed for the presence of varus, valgus, and any knee mal-alignment in 
their 20s, and currently. 
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2.2.2.6 Radiographic knee malalignment  
The anatomic axis measured on knee radiographs was used to calculate the 
mechanical axis using the formula described by Krause et al. (2005) The 
absolute value for deviation from the neutral (180o) was computed for each 
knee. Knees with up to 2o mal-alignment from neutral (180o) were considered 
to have neutral alignment. Knees with >2o varus, and >2o valgus were 
considered to have varus, and valgus knee mal-alignment. Risks were 
computed separately for each side. Absolute degree of mal-alignment was 
compared between knees with CC, and knees without CC, separately for 
right and left sides. Similarly risks were computed for valgus, varus, and any 
knee mal-alignment and knee CC on the same side.    
2.2.2.7 Occupational joint use 
Comprehensive information on tasks performed during all occupations to the 
date of recruitment was recorded for each participant. The longest held job 
was selected as the index job. For TJR cases, the occupational exposure 
was truncated at the time of TJR. Results from published literature on 
occupational risk factors for knee OA were used to select tasks that would be 
treated as risk factors in the analysis (Blagojevic et al 2010). Individuals were 
scored for risk factors in their longest held job. The following were coded as 
present or absent:  
x NQHHOLQJIRUKRXUVSHUGD\ 
x VTXDWWLQJIRUKRXUVSHUGD\ 
x KHDY\ZRUNVWDQGLQJIRUKRXUVSHUGD\ 
x lifting 25kg  times per week 
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x lifting 50kg or 100kg times per week 
Risks were computed for the presence of each occupational risk separately 
and for the presence of any occupational risk factor.   
2.2.2.8 Knee injury, or surgery 
All participants self-reported information about previous significant joint 
injuries. As the knee is a target site for CC only knee joint injury was 
considered for this analysis. Participants were considered to be exposed if 
they had a history of knee injury. In those with TJR this had to be prior to the 
joint replacement. Risks were computed for those with previous significant 
knee injury, with those without previous significant knee injury being the 
referent. Participants self-reported previous arthroscopy and/or 
meniscectomy. This was used to classify previous knee surgery as 
arthroscopy (+/- meniscectomy), and meniscectomy.  
2.2.2.9 Diuretic use 
Information about diuretic use, including name of the diuretic, and month, 
year of starting and stopping treatment was self-reported by GOAL 
participants. Diuretic intake was validated by asking the patients the name of 
the diuretic, and also by examining what proportion of patients self-reporting 
diuretics self-reported hypertension. Of those self-reporting diuretic intake, 
95% knew the name of the diuretic, and 87% also self-reported hypertension. 
This was used to calculate the number of years on thiazide or loop diuretics. 
As potassium sparing diuretics do not lead to hypomagnesemia, exposures 
to potassium sparing diuretics alone were disregarded. Similarly, diuretic 
exposures for <3 months was disregarded. Risks were computed for 
exposure to either loop or thiazide diuretic. The duration of exposure to 
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thiazide and loop diuretics was summated, and converted to tertiles. This 
was used to examine the dose-response relation between number of years 
on thiazide or loop diuretic and risk of CC.  
2.2.2.10 Bone mineral density 
Cortical BMD was estimated from metacarpal index calculated from the hand 
radiographs. Metacarpal index was calculated as (W-w)/W) where W is the 
total external diameter and w is the endosteal diameter of the mid-shaft of 
the 2nd metacarpal (Nielsen 2001). The trabecular BMD was measured 
directly using calcaneal ultrasound (Apollo). The trabecular BMD measures 
were normalised to yield z scores in the GOAL control population, which was 
then categorised as <-1SD, -1 to +1SD, and >1SD. Metacarpal index was 
converted to tertiles. Risks for CC were computed for higher trabecular and 
cortical BMD with the lowest tertile of trabecular and cortical BMD being the 
reference. 
2.2.2.11 Soft-tissue and vascular calcification 
Participants with peri-articular soft tissue calcification at the knee were 
considered to have soft-tissue calcification. Vascular calcification was only 
ascertained on the pelvic radiograph. Risks were computed for the 
associations between peri-articular soft tissue calcification at the knee, and 
CC at any site. Similarly risks were computed for the association between 
vascular calcification and CC at any site.    
2.2.3. Genetic risk factors 
The genetic study focused on examining associations between SNPs in 
genes involved in PPi metabolism and CC. This is a genetic replication study 
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examining previously published associations and does not seek to identify 
novel SNPs.    
A detailed literature search was carried out to identify SNPs in genes 
involved in PPi metabolism. SNPs were selected for genotyping if they met 
any one of the following criteria:   
1. previous reports of association with CC  
2. association with metabolic abnormlities and diseases associated with 
CPPD 
3. amino-acid changing SNP, and 
4. exonic location. 
SNPS were selected if they were known to occur in Caucasians, and 
had a minor allele frequency of > 0.05.  Seventeen SNPs were selected for 
genotyping for their association with CC, PPi levels, OA, and iron overload 
states (Table 15).  
Four SNPs in ANKH were selected for genotyping. One of this, the               
-4bp * WR $ WUDQVIRUPDWLRQ LQ WKH ¶-UTR region has previously been 
associated with sporadic CPPD in a hospital based case-control study from 
Oxford, UK. In this study, cases with CC were selected from rheumatology  
clinics, and controls were healthy blood donors (Zhang et al 2005).The minor 
allele of this SNP associated with CPPD with a genotype relative risk of 6.0 
(p=0.0002). Another SNP in ANKH, rs3045 associated with rotator cuff tear in 
a hospital based case-control study, and the minor allele resulted in low 
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intracellular PPi levels - a marker of high extracellular PPi levels ± in in vitro 
studies (Peach et al 2007). The other two SNPs in ANKH selected for 
genotyping associated with serum parathyroid levels in a study of 244 nuclear 
families (840 individuals) after correcting for age, gender, and BMI 
(Vistoropsky et al 2007). The AC haplotype of these two SNPs in ANKH 
(rs39968, and rs875525) associated with low parathyroid hormone levels 
(Vistoropsky et al 2007).    
Three TNAP SNPs were selected for genotyping. Of these, 
homozygosity of the amino acid changing SNP rs3200254 associated with 
both high BMD, and high TNAP enzyme activity in a study of over 500 
postmenopausal women from Japan (Goseki-Sone et al 2005). The higher 
TNAP activity was explained by a lower Michelis constant (Km) which reflects 
increased substrate affinity for the enzyme (Goseki-Sone et al 2005). rs 
4654760 associated with rotator ± cuff tear in a hospital based case-control 
study, and TNAP571 was the commonest cause of adult onset 
hypophosphatasia in a study of 361 unrelated samples sent to a tertiary 
reference laboratory (Peach et al 2007; Fauvert et al 2009). The latter SNP 
was selected as hypophosphatasia associates with CPPD.  
Five SNPs in ENPP1/PC1 gene were selected. Three of these 
(rs858342, rs1044498, rs1800949) have been associated with hand OA in a 
population based study of over 570 community dwelling Caucasians between 
age 18 and 90 (Suk et al 2005). Another SNP in this gene (rs943003) was 
selected for its association with obesity in a Finnish case control study of over 
240 morbidly obese cases, and over 480 lean controls (Valli-Jaakola et al 
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2008). The SNP rs28933977 was selected for its association with hand OA 
(Suk et al 2005), and generalised arterial calcification of infancy ± a condition 
caused by inactivating mutations in ENPP1, which leads to low PPi, and 
deposition of hydroxyapatite crystals in the vasculature (Cheng et al 2005). 
The other candidate SNPs were selected for their established associations 
with haemochromatosis (Alizadeh et al 2007), and iron overload (Benyamin 
et al 2009). *HQRW\SLQJ ZDV FDUULHG RXW E\ JHQHWLFLVWV DW $VWUD=HQHFD¶V
laboratories using the TaqMan method. If they were not able to develop an 
assay for the SNP, the genotyping was outsourced to Kbiosciences UK.  
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Table 15 Rationale for selecting single nucleotide polymorphisms 
Gene SNP Location Nucleotide 
change  
Amino acid  
change 
Disease or biochemical 
association 
ANKH -4bpGtoA  ¶-UTR G to A  No  CC 
 rs3045 ¶-UTR A to G/           
T to C  
No Rotator cuff tear 
 rs39968 Intron A to G/           
C to T  
No Low PTH 
 rs875525 Intron C to T/         
A to G  
No Low PTH 
TNAP rs3200254 Exon T to C Tyr to His Increased enzyme 
activity, increased BMD 
 
 rs4654760 Intron C to T  No Rotator cuff tear 
 TNAP571 Exon G to A  Glu to Lys  25% adult onset 
hypophosphatasia 
ENPP1/PC1 rs858342 Intron A to G  No  Hand OA 
 rs1044498 Exon A to C  Lys Gln Hand OA 
 rs1800949 Intron C to T  No Hand OA 
 rs28933977 Exon C to T Arg to Cys Hand OA, generalized 
arterial calcification 
 rs943003 Intron A to G  No Obesity 
HFE rs1800562 Exon G to A Cys to Tyr Haemochromatosis 
 rs1799945 Exon C to G His to Asp Haemochromatosis 
TFR rs1799852 Exon C to T No High transferrin 
 
 rs2280673 Intron  A to C  No  High transferrin 
 
 rs3811647 Intron  A to G  No  High transferrin 
(Zhang et al 2005; Peach et al 2007; Vistoropsky et al 2007; Goseki-Sone et 
al 2005; Fauvert et al 2009; Suk et al 2005; Valli-Jaakola et al 2008; Alizadeh 
et al 2007; Benyamin et al.2009) 
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All SNPs were checked for Hardy-Weinberg equilibrium (HWE) prior 
to analyzing genetic risk. According to the binary distribution of allele 
frequencies in the general population, sum of proportion of common 
homozygotes, rare homozygotes, and compound heterozygotes should be 1 
in the presence of a stable population i.e. p2 + q2 + 2pq = 1, where p is the 
frequency of one of the tested allele, and q, the frequency of the other allele 
is 1 - p.  The distribution of expected and observed genotype frequencies 
were compared using a chi-VTXDUH GLVWULEXWLRQ )LVKHUV¶ H[DFW WHVW Table 
16). If there was a significant difference in the observed and expected 
genotype frequencies (p <0.05), the alleles at that SNP were not in HWE 
suggesting genetic drift.  
Table 16 Chi square test for Hardy-Weinberg equilibrium 
Genotype Observed Expected 
Common homozygote A p2 
Rare homozygote B q2 
Heterozygote C 2pq 
 
Overall genotype risks (ORGENOTYPE) were computed for associations 
between different genotypes and CC. ORGENOTYPE is the OR for association 
between increasing number of tested alleles at the particular SNP, and risk of 
CC i.e. the risk of CC for each additional rare allele of that SNP. The p value 
of genotype OR was corrected for multiple tests using Bonferroni corrections. 
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Since we examined the association between 17 candidate SNPs, and CC, 
the ORGENOTYPE was considered significant if the p value was <0.003.    
2.2.4. Summation of radiographic structural changes 
Scores allocated to individual radiographic structural changes at different 
sites or compartments within a joint were summated to yield a global 
radiographic score. Due to their additive nature, global scores reflect the 
severity of structural changes at a joint. The strategy for summation varied 
according to the joint.  
At the knee: Osteophytes were scored from 0 - 5 at eight sites in the knee ± 
4 each in the TFJ, and the PFJ. The osteophyte scores were added to yield a 
global score reflecting the amount of osteophytosis in the index knee 
(maximum score 40). Joint space narrowing was graded as -1 to 5 for the 
two TFJ, and PFJ compartment on each side. For calculating global JSN 
score for each knee, negative scores were transformed to 0 and JSN scores 
for each compartment were summated. Separate scores were calculated for 
each side. Attrition was scored as present or absent on each side and was 
analysed as a dichotomous variable.     
At the hip: Osteophytes at the hip were scored on a 0 - 3 scale at three sites 
in each hip. The osteophyte scores were summated using the same 
approach as at the knee (maximum score 9). Minimum joint space width 
measured at each hip in millimeteres correct to two decimal points was 
converted to tertiles. Other radiographic phenotypes like sclerosis, cysts, and 
attrition were scored as present or absent on each side, and were analysed 
as dichotomous variables.     
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At the wrist: Osteophytes were scored from 0 - 3, in the radio-carpal, mid-
carpal, and common carpo-metacarpal joints. These were added to yield a 
global score reflecting osteophytosis in the index wrist (maximum score 9). 
Joint space narrowing was graded as 0 - 3 for each of the radio-carpal, mid-
carpal, and common carpo-metacarpal joints. These were added to yield a 
global score reflecting joint space narrowing at the index wrist (maximum 
score 9). Separate scores were calculated for each side. Other radiographic 
phenotypes like sclerosis, and cysts, have been scored as present or absent 
on each side, and were treated as dichotomous variables.     
At the 1st carpo-metacarpal, and trapezio-scaphoid joint: Osteophytes and 
joint space narrowing were allocated a single global score on a 0-3 scale at 
these joints. Other radiographic phenotypes like sclerosis, and cysts, have 
been scored as present or absent on each side, and were treated as 
dichotomous variables. 
At the MCPJs: Osteophytes were scored from 0-3 at each MCPJ. The 
osteophyte scores from the 2nd to 5th MCPJ in each hand were added to yield 
a global score reflecting the amount of osteophytosis at the MCPJs in one 
hand (maximum score 12). Joint space narrowing on a 0-3 scale at each 
MCPJ was summated to yield a global joint space narrowing score 
(maximum score 12) for the MCPJs in each hand. Other radiographic 
phenotypes like sclerosis, and cysts were scored as present or absent on 
each side, and were regarded as dichotomous variables.    
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2.2.5. Risk estimation for summated radiographic scores 
Osteophyte scores at each joint were converted to tertiles. Risks were 
computed for association between increasing tertiles of osteophytes score 
and CC at that joint with the 1st tertile being referent. A similar approach was 
adopted for joint space narrowing. Risks were computed for association 
between sclerosis, cysts, and attrition in the index joint, and CC at the same 
joint. All associations were examined to identify if this was a local effect.  If 
local effects were present, further analysis was carried out to look for distant 
effects ± i.e. whether CC at distant joints affected the phenotype of OA at the 
index site. Joints with CC at the index site were excluded from this analysis.    
2.2.5 Statistical analysis 
Mean (S.D.) and n (%) were used for descriptive studies. The prevalence of 
CC and its 95% confidence interval (CI) was calculated as follows.  
p = c/n    95% CI = p +/- [¥S-p)/n. 
p - prevalence of CC   c - number of participants with CC  
n - total number of participants  
The overall prevalence (95% (CI)) of CC was calculated. The 
prevalence of CC was calculated at each joint area for unilateral CC, for 
bilateral CC, and for isolated CC i.e. CC at a target joint in the absence of 
CC at any of the distant joints. Similarly, the prevalence of CC was 
calculated for medial and lateral compartment TFJ and for fibro- and hyaline 
cartilage involvement at the knee. 
Cluster analysis was used to test whether CC is likely to occur in 
multiple joints in the same individual i.e. to identify if there is a systemic 
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predisposition to CC. For this, we calculated the number of subjects who 
would have 0, 1, 2, 3, 4 or 5 joint areas with CC, assuming that the presence 
of this CC in different regions is independent. We then compared the 
observed frequency of subjects with number of joint areas affected with the 
expected frequency using a chi-square distribution. 
Independent sample T-test and chi-square test were used to compare 
cases and controls. Kappa statistic (k DQG LWV¶  &, ZHUH FDOFXODWHG WR
assess the intra-observer agreement for consistency, and inter- observer 
agreement for absolute agreement using a two way mixed model.  OR (95% 
CI) were calculated to examine associations. Binary logistic regression was 
used to adjust for confounders.  
a) the associations between CC at the index joint and CC at distant 
joints were adjusted for age at hospital visit (tertiles), gender (male 0, 
female 1), BMI (tertiles), and definite OA at distant joints (absent 0, 
present 1). OA was considered to be present at the distant joints if 
WKH.	/VFRUHZDVDWHLWKHUKLSDWHLWKHUNQHHDQGWKHUHZDV
definite joint space narrowing at either wrist i.e at either radio-carpal, 
mid-carpal, or common carpometacarpal joints. 
b) the associations between risk factors and CC were adjusted for age 
at hospital visit (tertiles), gender (female 1, male 0), BMI (tertiles), 
NQHH2$.	/VFRUHDQGKLS2$.	/VFRUH&XUUHQW%0,
was used when adjusting BMI for all risk factors except for self-
reported knee mal-alignment in 20s when BMI in their 20s was used.  
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For all SNPs in HWE overall genotype risks were calculated and 
adjusted as above.  
c) In those with OA at the index joint, the association between CC and 
structural radiographic changes was adjusted for age (tertiles), 
gender, and BMI (tertiles).  
In this study tertiles were used to categorize continuous variables for 
examining associations using binary logistic regression. This approach to 
categorizing continuous variables gives meaningful ORs for each unit 
increase in the category of the exposure variable. This can then be easily 
communicated to the reader. If continuous variables are used on their own, 
the OR for each unit increase in the exposure variable is usually very small 
and difficult to communicate to the reader. Also, categorizing continuous 
variables allows for the examination of dose-response between increasing 
levels of exposure of interest and the outcome. This is not possible if only 
continuous variable are used as an exposure of interest.  
Statistical significance was set at p<0.05 (two sided analysis), except for 
ORGENOTYPE for which statistical significane was set at <0.003. All analyses 
were carried out using SPSS v14.   
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Chapter 3 Radiographic distribution of chondrocalcinosis                  
 
Aims: The overall aim of this study was to examine the distribution of 
radiographic CC in participants of GOAL study.  The specific objectives were 
to: 
1) describe the prevalence of CC at the knees, hips, symphysis pubis, wrists 
and that of MCPJ calcification with an emphasis on laterality and 
sidedness 
2) compare the prevalence of CC at the hips, symphysis pubis, wrists, and 
MCPJ calcification in the presence and absence of knee CC 
3) compare the prevalence of CC at the medial and lateral TFJ compartment, 
and in the fibro- and hyaline cartilage of the TFJ 
4) examine if there is a consititutional predisposition to CC  
5) examine if there is an association between CC at referent and distant joint  
6) examine if bilateral CC at referent joint has a higher risk of CC at distant 
joints than unilateral CC at referent joint. 
  
154 
 
Results: Of the 3170 participants, information about CC at any pelvis, knee, 
or hand radiographs were available for 3139 participants. Out of these 3139 
participants, 431 participants had CC at any one joint. The overall prevalence 
(95% CI) of CC was 13.7 (12.5-14.9) %. The knee was the commonest site 
of CC, being affected in 8.0% of GOAL participants. Other joints involved in 
descending order of frequency were: wrists (6.9%), hips (5.0%), and 
symphysis pubis (3.6%). Isolated CC (i.e. CC at any one joint area only) 
occurred most frequently at the knee (2.6%), and at the wrist (2.3%) (Table 
17). There was no predilection for MCPJ calcification, or CC to occur on any 
side (Table 17). CC was significantly more likely to be bilateral at the knees, 
and wrists, while it was more likely to be unilateral at the hips (Table 17). 
MCPJ calcification was least frequent and commonly bilateral (Table 17).  
Table 17 Prevalence of chondrocalcinosis at individual joints 
  Prevalence (95%CI) of CC in GOAL participants 
Index              
joint 
N Overall 
(%) 
Right      
(%) 
Left         
(%) 
Unilateral 
(%) 
Bilateral 
(%) 
Isolated  
(%) 
Knee 3134 8.0        
(7.0-8.9) 
6.7        
(5.8-7.5) 
6.0        
(5.2-6.8) 
4.0        
(4.7-5.4) 
3.3        
(2.7-3.9) 
2.6          
(2.2-3.3) 
Wrist 3130 6.9        
(6.0-7.8) 
5.4        
(4.6-6.2) 
5.8        
(5.0-6.6) 
2.7        
(2.1-3.2) 
4.3        
(3.6-4.9) 
2.3          
(1.8-2.9) 
Hip 3144 5.0        
(4.3-5.9) 
4.0        
(3.3-4.7) 
3.0        
(2.4-3.6) 
3.1        
(2.5-3.7) 
2.0        
(1.5-2.5) 
1.4          
(1.0-1.8) 
Symphysis 3168 3.6        
(2.9-4.2) 
N/A N/A N/A N/A 0.8          
(0.5-1.8) 
Any MCPJ 3130 1.5        
(1.1-2.0) 
0.9        
(0.6-1.2) 
1.1        
(0.7-1.4) 
0.4        
(0.2-0.6) 
1.1        
(0.8-1.5) 
0.1          
(0.0-0.2) 
N/A not applicable 
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Among the MCPJs, the 2nd and 3rd MCPJs were most likely to have 
calcification (Figure 36).  
 
Figure 36 Calcification at MCPJs 
n = number of participants with MCPJ calcification at that joint  
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When present, CC occurred at more than one joint in approximately two-
thirds of the GOAL participants. CC was present at one joint in 35.3%, at two 
joints in 23.4%, and at more than two joints in 41.3% of GOAL participants 
(Figure 37). 
 
Figure 37 Number of joints with chondrocalcinosis 
  
157 
 
CC was common at other joints without any knee involvement. For example, 
44.4% of wrist CC, 45.9% of hip CC, 45.5% of symphysis pubis CC, and 
31.3% of MCPJ calcification occurred without knee CC (Table 18).  
Table 18 Chondrocalcinosis at other joints in the presence or absence 
of knee involvement 
 Total  Knee CC +ve 
n=250 
Knee CC ±ve 
n=181 
 
Percent with CC at index 
joint without knee CC 
Wrist 216 120 96 44.4% 
Hip 157 85 72 45.9% 
Symphysis pubis 112 61 51 45.5% 
Any MCPJ 48 33 15 31.3% 
Therefore, only 58.4% of GOAL participants with CC at any site (knees, 
wrists, hips, symphysis pubis), or with MCPJ calcification could be identified 
on radiographs of both knees only (Figure 38). This proportion increased to 
82.4% if the pelvis radiograph, and to 81.5% if both wrist and hand 
radiographs, were also obtained.  
 
 
 
 
 
 
 
 
Figure 38 
Articular distribution of chondrocalcinosis 
Knee  
85 
Hand/wrist 
75 
Hip/symphysis 
79  
64 
40 61 
24 
2690 
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In those with CC at two or more joint areas, the common patterns of location 
of CC were: knee and wrist/hands (14.3%); knee, wrist/hands, hips, 
symphysis pubis (6.8%); knee, wrist/hands, hips (6.1%). The number of 
participants with CC in these locations is detailed in Figure 39.  
 
Figure 39 Number of patients with chondrocalcinosis at  areas 
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When present, knee CC commonly affected both medial and lateral TFJ 
compartments (Figure 40). 67% participants with right knee CC, and 59% 
participants with left knee CC had involvement of both TFJ compartments. 
CC was more common in the lateral TFJ compartment than in the medial 
TFJ compartment at both knees (Figure 40). The absolute difference in 
prevalence (95%CI) of CC between the lateral and medial compartment of 
TFJ was 15.2% (8.1-22.1) for the right, and 15.4% (7.1-23.0) for the left knee 
(Figure 40).  
 
Figure 40 Compartmental distribution of chondrocalcinosis at TFJs 
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At the knee, fibro- and hyaline cartilage CC co-existed in 48.6% of right TFJs 
and in 40.0% of left TFJs (Figure 41). However, at the TFJs CC affected the 
fibro cartilaginous meniscus more frequently than the intra-articular hyaline 
cartilage. The difference in prevalence (95% CI) between fibrocartilage and 
hyaline cartilage CC was 34.6% (26.9-42.3) for right and 32.6% (23.3-40.4) 
for left TFJ. Similarly, isolated fibrocartilage involvement was more common 
than isolated hyaline cartilage involvement at both TFJs ± 42.8% vs. 8.2% at 
the right, and 46.3% vs. 13.7% at the left TFJs. 
 
Figure 41 Cartilaginous distribution of chondrocalcinosis at TFJs 
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Constitutional predisposition to CC: 3118 patients had information about CC 
recorded at all joints. Of these 428 patients had CC at any joint. 931 patients 
did not have any radiographic evidence of OA at any knees, hips, or wrists. 
On cluster analysis, joints with CC clustered together more than would be 
expected by chance alone (Table 19). This was present when patients with 
knee, hip, and wrist OA were excluded.   
Table 19 Cluster analysis: systemic risk for chondrocalcinosis 
Number of regions 
with CC 
All participants Without OA at knee, hips or wirst 
Observed Expected Observed Expected 
0 2690 2257.13 872 850.56 
1 219 782.93 37 78.00 
2 111 74.55 12 2.41 
3 57 3.32 5 0.031 
 41 0.071 5 01 
Chi square(d.f.), p 2974.96 (4), <0.001 92.25 (4), p<0.001 
1
considered as 1 for calculating chi-square statistic 
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On binary logistic regression, CC at any one joint area associated with CC at 
distant joints. The association was present for all joint pairs, and persisted 
after adjusting for age, gender, BMI, and OA at the distant joints (Table 20).  
Table 20 Association between chondrocalcinosis at distant joints 
Referent joint aOR (95%CI)
1
 for CC at distant joints 
Knee Wrist Hip           Symphysis 
pubis        
MCPJs 
Knee -/- 27.23           
(19.14-38.74) 
19.63           
(13.67-28.19) 
17.60           
(11.60-22.60) 
23.97           
(12.57-45.70) 
Wrist 22.35           
(15.89-31.43) 
-/- 16.88           
(11.59-24.57) 
15.56           
(10.18-23.79) 
66.95           
(30.05-149.14) 
Hip 18.87           
(13.04-27.30) 
19.67           
(13.29-29.10) 
-/- 37.39           
(24.34-57.42) 
18.72           
(10.05-34.85) 
Symphysis 
Pubis 
16.82          
(11.01-25.69) 
17.03           
(11.00-26.36) 
37.29           
(24.29-57.25) 
-/- 5.40             
(2.39-12.21) 
Any MCPJ 21.04          
(11.04-40.11) 
74.51           
(33.10-167.74) 
19.42           
(10.56-35.72) 
5.17             
(2.33-11.47) 
-/- 
1Adjusted for age (tertiles), gender (female 1, male 0), BMI (tertiles), and OA at distant site except for 
symphysis pubis where adjustment for OA was not carried out. 
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Next, we examined the association between bilateral CC at one joint and CC 
at distant joints, with unilateral CC at the index joint being the referent. 
Compared to unilateral knee CC, bilateral knee CC associated with CC at 
wrists, hips, symphysis pubis and MCPJs. Similarly, compared to unilateral 
wrist CC, bilateral wrist CC associated with CC at the knee, hips and MCPJs; 
compared to unilateral hip CC, bilateral hip CC associated with CC at the 
knee, wrist and MCPJs; and compared to unilateral MCPJ calcification, 
bilateral MCPJ calcification associated with CC at the hip (Table 21). 
Table 21 Association between bilateral chondrocalcinosis at one joint 
area and distant chondrocalcinosis 
Referent 
joint 
aOR (95%CI)1 for CC at distant joints 
Knee Wrist Hip Symphysis 
pubis 
MCPJs 
Knee -/- 2.23             
(1.27-3.93) 
3.79             
(2.06-6.98) 
2.21             
(1.17-4.17) 
2.78           
(1.13-6.86) 
Wrist 3.38           
(1.82-6.24) 
-/- 2.15             
(1.44-4.04) 
1.86             
(0.93-3.72) 
2.58           
(1.11-5.99) 
Hip 3.15           
(1.51-6.56) 
2.69             
(1.27-5.73) 
-/- 1.52             
(0.77-2.97) 
4.22           
(1.53-11.68) 
Symphysis 
Pubis 
-/- -/- -/- -/- -/- 
Any MCPJ 2.37           
(0.43-12.96) 
-/-2 6.91             
(1.40-34.26) 
2.39             
(0.39-14.82) 
-/- 
1Adjusted for age (tertiles), gender (female 1, male 0), BMI (tertiles) and definite OA at distant site. 2 No 
cases. 
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Key results:  
x 13.7% GOAL participants had CC at any site.  
x Knee was the commonest location of CC. 
x There was no predilection for MCPJ calcification, or CC to occur on 
any side. 
x MCPJ calcification and CC were more likely to be bilateral except at 
the hips. 
x 2nd and 3rd MCPJs were the commonest site for MCPJ calcification.  
x CC commonly occurred at other joints without any knee involvement.  
x Knee CC was more frequently in the lateral TFJ compartment than in 
the medial TFJ compartment, and in fibro- than in the hyaline articular 
cartilage.  
x There was evidence for a systemic predisposition to CC. 
Discussion: In this study, the overall prevalence of CC in knee, hand, and 
pelvis radiographs was 13.7%. The prevalence of CC at knees (8.0%), knees 
and pelvis (10.6%), and knee and wrists (10.4%) reported in this study are 
similar to those reported by previous community based surveys. According to 
these surveys, the prevalence of knee CC is 8.1% (Felson et al 1989), that of 
knees and pelvis is 10.4% (Ramonda et al 2009), and that of knees and 
hands is 10% (Sanmarti et al 1993). 
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Despite a higher prevalence of OA, the prevalence of CC at knees, 
knees and pelvis, and knee and wrists reported in this study are similar to 
those reported in community based surveys (Felson et al 1989; Sanmarti et 
al 1993; Ramonda et al 2009). This apparently surprising finding may be 
explained by the relationship between age, OA, and CC. GOAL participants 
have a high prevalence of large joint OA so they would be expected to have 
at least a two-fold higher prevalence of CC (Felson et al 1989). However, 
GOAL participants were also approximately ten years younger than those in 
community based surveys of CC (Felson et al 1989). Since the prevalence of 
CC halves for each 10 year fall in age, this probably compensates for the 
increase in prevalence of CC resulting from a high prevalence of OA (Felson 
et al 1989).  
$OWKRXJKOLPLWHGE\LW¶VVWXG\GHVLJQWKLVLVWKHILUVWODUJHUDGLRJUDSKLF
study of CC to include radiographs of all three regions commonly affected by 
CC i.e. the knees, pelvis, and hands. The other two radiographic surverys to 
systematically examine the prevalence of CC in radiographs of hands, 
knees, and pelvis were small, and included in-patients (Wilkins et al 1983), or 
symptomatic out-patients only (Gordon et al 1984).  
The overall prevalence of CC in this study is lower than that observed 
in radiographic surveys of acute geriatric inpatients (34.0%) (Wilkins et al 
1983). Similarly, the prevalence of knee CC is lower than that observed in 
elderly residential home residents (9.6%) (Ellman et al 1975). This may be 
because participants in GOAL are younger (mean age 67 years) than those 
in these two studies. The mean age of participants in the previous two 
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studies were 79.4 years (Wilkins et al 1983), and 82.6 years (Ellman et al 
1975) respectively. However, the prevalence of CC reported in the current 
study derived from an out-patient hospital based population with a high 
prevalence of large joint OA should be interpreted with caution, and may 
have limited generalisability to the general population.   
We report that the knee is the commonest site of CC. This is in 
keeping with most previous reports examining the prevalence of CC (Ellman 
et al 1975; Bergstrom et al 1986b; Sanmarti et al 1993; Ramonda et al 
2009). In our study, the prevalence of CC at other sites in descending order 
of frequency was wrists, hips, and symphysis pubis.  
While the published literature is unanimous about the joint most 
commonly affected by CC, there is significant disagreement about the 
second most frequent site of CC. Some studies report that the wrist is the 
second most frequently involved joint (McCarty et al 1963; Ellman et al 1975; 
Resnick et al 1977a; Balsa et al 1990; Louthrenoo et al 1999) while others 
report that the symphysis pubis is the second most commonly affected site 
(Twigg et al 1964; Fam et al 1981; Wilkins et al 1983; Gordon et al 1984). 
One early report suggested that the hip is the second most frequently 
involved joint (Zitnan et al 1963) but this has not been supported by any 
subsequent study. In a hospital based study of 69 patients with CPPD, hip 
CC was less common than knee CC, wrist CC, and MCPJ calcification 
(Riestra et al 1985). A detailed review highlights the uncertainty around the 
second most frequently affected joint (Genant 1976). However, since the 
present study is the largest study to date to examine the relative frequency of 
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CC at commonly affected sites, within the study limitations we can say with 
reasonable confidence that wrist is the second most common site for CC.  
In this study, CC was more prevalent at the hips than at the 
symphysis pubis. This is in keeping with previous observations (Twigg et al 
1964; Fam et al 1981; Wilkins et al 1983; Gordon et al 1984). However, in a 
large community based survey of older adults symphysis pubis calcification 
was more common than hip CC (Ramonda et al 2009). 33.1% of participants 
with CC at knees, hips, or symphysis pubis had symphysis pubis calcification 
while only 3.6% of these participants had hip CC. This difference from our 
study may be because approximately one-third of GOAL participants were 
selected because of severe symptomatic hip OA and that participants in 
GOAL were younger ± older age may have a greater influence on the 
prevalence of CC in the symphysis pubis as this joint is not affected by OA .    
As in previous reports, MCPJ calcification occurred in just over 11% of 
participants with CC (Sanmarti et al 1993). When present, MCPJ calcification 
most commonly affected the 2nd and 3rd MCPJs. This is in keeping with 
previous observations (Resnick et al 1977a).          
We did not find a predilection for knee, wrist, or hip CC and MCPJ 
calcification to occur preferentially on either the right or left side. This is in 
keeping with most previous observations (Felson et al 1989; Neame et al 
2003). There is a single previous report of CC preferentially affecting one 
side over the other. In a community based survey, unilateral CC was 
reported to be more common in the right than in the left knee (Ramonda et al 
2009).  
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In the current study, CC was more likely to be bilateral at the knee and 
wrist. This concurs with previous reports (McCarty et al 1963; Zitnan et al 
1963; Bocher et al 1965; Ellman et al 1975; Genant 1976; Dieppe et al 1982; 
Wilkins et al 1983; Felson et al 1989; Louthrenoo et al 1999; Ramonda et al 
2009). However, we found that CC was significantly more likely to be 
unilateral at the hip ± a finding which is not in keeping with previous reports 
(McCarty et al 1963; Zitnan et al 1963; Ellman et al 1975; Genant 1976; 
Wilkins et al 1983). This finding suggests that hip CC may be a result of joint 
specific predisposition unlike CC at other joints. A similar pattern is observed 
for hip OA which is more frequently unilateral (Tepper et al 1993), and 
related to joint specific risk factors e.g. injury rather than generalized risk 
factors e.g. obesity (Cooper et al 1998). 
We report that 42% of patients with CC have involvement of hips, 
symphysis pubis, wrists, and MCPJ calcification in the absence of knee CC. 
Similar findings have been reported before. Two hospital based studies 
reported that CC can occur in the absence of knee involvement in 25.0 to 
33.3% of cases (McCarty et al 1963; Wilkins et al 1983). However, there are 
several reports which contradict this observation, and suggest that it is rare 
to get CC at other joints in the absence of knee involvement. While one 
report suggests that CC does not occur in the absence of knee involvement 
(Fam et al 1981), other studies suggest that CC in the absence of knee 
involvement is rare, and occurs in between 3.4% - 11.0% patients only 
(Zitnan et al 1963; Ellman et al 1975; Gordon et al 1984; Sanmarti et al 1993; 
Louthrenoo et al 1999; Ramonda et al 2009).  
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Moreover, two hospital based studies of symptomatic CPPD patients 
have examined the relative distribution of CC at knees, wrists, and 
symphysis pubis (Gordon et al 1984; Canhao et al 2001) (Figure 42). They 
suggest that CC is extremely unlikely to occur at the wrists and symphysis 
pubis in the absence of knee CC. However, this observation may be because 
patients with symptomatic CPPD at the knee are over-represented in these 
hospital based studies since these patients are more likely to seek medical 
attention. 
 
Figure 42 Distribution of chondrocalcinosis at knee, wrist, and 
symphysis pubis in two hospital based studies 
Only 58.4% of GOAL participants with CC at any site (knees, wrists, 
hips, symphysis pubis or MCPJ calcification) could be identified using 
radiographs of both knees. Moreover, only 82.4% of participants could be 
identified if the pelvic radiograph was also included, and 81.5% of 
participants could be identified if both wrists and hand radiographs were also 
included. This observation has significant implications for case ascertainment 
for epidemiological and genetic studies of CC, i.e. controls should have no 
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CC at any of these three joint areas, and a large proportion of cases may 
have CC at wrist, hips or symphysis pubis and be missed if knee radiographs 
alone are used to screen for CC cases.  
As previously reported, we found that knee CC is more common in the 
lateral TFJ compartment than in the medial TFJ compartment (Skinner et al 
1969; Wilkins et al 1983; Riestra et al 1985; Felson et al 1989; Ramonda et 
al 2009). The cause underlying this well recognised phenomenon is not well 
understood.  
We also found that CC occurs more frequently in fibrocartilage than in 
articular hyaline cartilage. This is in keeping with previous observations 
(McCarty et al 1963; Zitnan et al 1963; Twigg et al 1964; Genant 1976; Fam 
et al 1981; Wilkins et al 1983), and may be due, at least in part, to the fact 
that fibrocartilage chondrocytes secrete more PPi than chondrocytes from 
articular hyaline cartilage (Ryan et al 1981). Other factors such as cartilage 
matrix changes may also play a role in promoting CC.      
   We found evidence for systemic predisposition to CC, both on 
cluster analysis, and on examination of association between CC at distant 
sites. This persisted after adjusting for confounding factors such as age, 
gender, BMI and OA at the distant site. This association was observed at all 
joint pairs and supports the hypothesis that CC, at least in part, results from 
a systemic predisposition and is not only a consequence of local joint 
abnormality or structural arthropathy alone. Although patients with poly-
articular CC are well recognised (McCarty et al 1963; Twigg et al 1964; 
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Bocher et al 1965), this is the first systematic study examining the systemic 
predisposition to CC.  
We also found that bilateral CC at the knee was more likely than 
unilateral CC to associate with CC at distant joints. This association 
persisted after adjusting for age, gender, BMI and OA at the distant joints. 
This is a novel observation that suggests the presence of a dose-response 
relationship between extent of crystal deposition at one site and risk of CC at 
distant sites, and further supports the view that CC, at least in part, results 
from a systemic constitutional predisposition rather than being a 
consequence of local joint pathology alone. Similar associations were 
observed for bilateral CC at wrists, hips and distant joint CC. However, the 
adjusted OR for these associations was not statistically significant at the 
symphysis pubis.  
This is the largest systematic radiographic study to examine the 
overall prevalence of CC using radiographs of knees, pelvis and hands in 
well characterised participants; and to examine the prevalence of CC at 
individual joints both in the presence and absence of knee CC. This is also 
the first study to examine the association between CC at distant joints, and to 
elicit a dose-response relationship between CC at referent and distant joint. It 
validates previous observations on the prevalence of CC and on 
compartmental and cartilaginous localization of knee CC. The findings 
suggest that CC, at least in part, results from a generalised predisposition 
and is not a result of local joint disease alone.  
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However, there are significant caveats to the findings. Firstly, this is a 
hospital based study carried out by reconstituting case and control group in a 
cohort assembled to examine risk factors of large joint OA. Thus, the study 
sample does not resemble a community based population. Two-thirds of 
participants had severe symptomatic hip or knee OA and the remaining had 
no radiographic or clinical features of hip or knee OA. The study design 
therefore limits the generalisability of the overall and joint-specific prevalence 
of CC.  However, the face validity of the results is supported by the fact that 
the prevalence of CC at the knee (8.0%), knee and pelvis (11.9%), and knee 
and wrist (11.1%) reported here is in keeping with that observed in large 
radiographic surveys (Felson et al 1989; Sanmarti et al 1993; Ramonda et al 
2009). Secondly, the association between CC at distant joints may be 
confounded by a systemic predisposition to OA. However, we have tried to 
minimise this bias by adjusting for OA at the index joint. The dose-response 
relationship between CC at the referent, and index joints further supports the 
existence of a systemic predisposition to CC. The results about the intra-
articular distribution of CC should also be interpreted with caution as a large 
proportion of patients had knee OA requiring joint replacement surgery, and 
CC may not be easily visualised in the affected compartments. However, our 
findings agree with the other studies providing face validity. Finally, we only 
ascertained the presence of CC on plain radiographs which are insensitive 
for the detection of CC (Ellabban et al 2011). The sensitivity of plain 
radiographs for the detection of CC may be further impaired in those with OA 
requiring joint replacement. Therefore, the findings should be replicated in a 
community based study, preferably using ultrasound.   
